Aradhana M Venkatesan, M.D., FSAR, FSIR, FACR
Department of Abdominal Imaging, Division of Diagnostic Imaging
About Dr. Aradhana M Venkatesan
Dr. Venkatesan joined The University of Texas MD Anderson (UTMDACC) in 2014 as a Tenure Track Associate Professor of Radiology and Director of Translational Research for the Dept. of Abdominal Imaging. In 2020, she was promoted to Full Professor with early award of Term Tenure and she received the UTMDACC President’s Recognition of Faculty Excellence Award in the Category of Research Excellence. Dr. Venkatesan earned her medical degree from Harvard Medical School. She also holds dual undergraduate degrees in Biology and English Literature from Swarthmore College. Her training includes two fellowships, one in Abdominal Imaging and Interventional Radiology and one in Musculoskeletal Imaging and Intervention, both from Massachusetts General Hospital. Dr. Venkatesan also completed her residency at Massachusetts General Hospital, where she served as Chief Resident.
Before joining MD Anderson, Dr. Venkatesan was a Staff Clinician and Investigator in the Radiology and Imaging Sciences Department and Center for Interventional Oncology at the NIH Clinical Center in Bethesda, MD (2007-2014). There, she provided expertise in diagnostic body imaging and nonvascular image-guided interventions. She served as a principal investigator on clinical trials pertaining to the use of MRI guided high intensity focused ultrasound, for which she received the NIH Clinical Center Director’s Award in 2010. She also served as an associate investigator on multiple NIH intramural clinical trials, and led educational initiatives for the intramural NIH community, including the quarterly NIH Clinical Center Clinicopathologic Grand Rounds.
As a faculty member at MD Anderson, Dr. Venkatesan provides radiology care to MD Anderson patients across all the abdominal imaging modalities offered by the Abdominal Imaging Department. This includes radiography, fluoroscopy, CT, MRI, inpatient and outpatient ultrasound and ultrasound-guided biopsy services. Care is provided to patients in the outpatient, inpatient and Acute Cancer Care Center (ACCC) setting.
In addition to clinical service, Dr. Venkatesan has served as the Abdominal Imaging Department’s modality Director for MRI, managing the abdominal MRI needs for patients, referring clinicians, faculty, trainees and staff across a >30 magnet fleet. As modality Director for MRI, she supervised image quality and provided support for faculty, trainees and technologist education and development. She collaborated with MR technologists and physicists, as well as departmental, Division level and institutional stakeholders to ensure high quality imaging, protocol efficiency, radiologist and referring clinician satisfaction, and optimal patient experiences. She worked with industry partners to ensure the latest technology was integrated into departmental practice in a timely and effective manner.
Dr.
Venkatesan’s current research endeavors focus on the development of novel
imaging biomarkers to enable risk stratification, adaptive therapy planning and
surrogate endpoint use in the treatment of genitourinary (GU) and gynecologic
(GYN) malignancies. One of her research focus areas is the development and
optimization of imaging techniques to facilitate adaptive image guided
radiotherapy. She also maintains active collaborative interests on the use of
novel navigation techniques to guide oncology therapies and in the development
of new image guided therapies for cancer. Her research portfolio
has comprised basic science, translational and clinical research projects,
supported by institutional, foundation, philanthropic and federal funding
sources.
Dr. Venkatesan has published over 100 peer reviewed publications, multiple book chapters, scientific abstracts & educational exhibits. In addition to her own accomplishments, she has mentored and sponsored numerous trainees and junior faculty throughout her career. Her track record including the successful mentorship and sponsorship of numerous including radiology clinicians, clinician-educators & clinician-scientists as well as imaging physicists & radiation physicists. She has also served as the PhD thesis advisor for multiple successful PhD candidates within the MDACC Division of Diagnostic Imaging.
Dr. Venkatesan is Board Certified by the American Board of Radiology. She is a Fellow in the Society of Interventional Radiology, a Fellow in the Society of Abdominal Radiology and a Fellow in the American College of Radiology. She is a member of the Texas Radiological Society, the American College of Radiology (ACR), the Radiological Society of North America, the Society of Abdominal Radiology, the Sigma Xi Scientific Research Society, and the American Association for the Advancement of Science.
Present Title & Affiliation
Primary Appointment
Professor, Department of Abdominal Imaging, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Professor, Department of Abdominal Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX
Associate Member, The University of Texas MD Anderson Cancer Center UT Health Graduate School of Biomedical Sciences Medical Physics Graduate Program, Houston, TX
Research Interests
Imaging biomarkers for genitourinary and gynecologic malignancy; Image-guided therapies for cancer.
Clinical Interests
Genitourinary and gynecologic malignancy
Education & Training
Degree-Granting Education
| 2001 | Harvard Medical School, Boston, Massachusetts, US, MD |
| 1995 | Swarthmore College, Swarthmore, Pennsylvania, US, Biology, BA |
| 1995 | Swarthmore College, Swarthmore, Pennsylvania, US, English Literature, BA |
Postgraduate Training
| 2012-2012 | Certification, Certified Clinical Research Professional (CCRP), N/A |
| 2006-2007 | Clinical Fellowship, Musculoskeletal Imaging and Intervention, Massachusetts General Hospital, Boston, Maryland |
| 2005-2006 | Focused Year, Abdominal Imaging and Intervention, Massachusetts General Hospital, Boston, Massachusetts |
| 2002-2006 | Clinical Residency, Diagnostic Radiology, Chief Resident, Massachusetts General Hospital, Boston, Maryland |
| 2001-2002 | Clinical Internship, The Lahey Clinic, Burlington, Massachusetts |
| 1999-2000 | Research Fellowship, Howard Hughes Medical Institute Research Fellowship for Medical Students, Brigham and Women's Hospital, Boston, Massachusetts |
Board Certifications
| 2006 | American Board of Radiology (Oral) |
| 2005 | American Board of Radiology (Written) |
| 2003 | American Board of Radiology (Physics) |
Experience & Service
Academic Appointments
Associate Professor, Department of Abdominal Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, 2019 - 2020
Associate Professor, Department of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2014 - 2019
Staff Clinician, NIH Clinical Center and NIH Center for Interventional Oncology, Bethesda, MD, 2007 - 2014
Other Appointments/Responsibilities
Gyn and OB (Gyn and OB 2) - Member, ACR Appropriateness Criteria, 2024 - 2022
Gyn and OB (Gyn and OB 2) - Panel Chair, ACR Appropriateness Criteria Committee, 2024 - 2026
Gyn and OB (Gyn and OB 2) - Panel Vice Chair, ACR Appropriateness Criteria, 2022 - 2024
Co-Chair of Research Sub-division, Society of Abdominal Radiology Uterine/Ovarian Cancer Disease Focused Panel, Houston, TX, 2019 - Present
Member, NRG Oncology Liaison for Gynecologic Imaging Trials, Houston, TX, 2018 - Present
ACR Committee on Membership Retention, ACR Committee, Reston, VA, 2016 - Present
Urologic (Uro 2) - Member, ACR Appropriateness Criteria, 2016 - 2020
Criteria Expert Panel, ACR Appropriateness, Reston, VA, 2016 - Present
Committee Member, American Roentgen Ray Society Scientific Program Review Subcommittee (Urinary/Prostate), Leesburg, 2014 - Present
Committee Member, Radiological Society of North America Uroradiology Educational Exhibits Committee, Chicago, 2014 - Present
Committee Member, American College of Radiology (ACR) Commission on Interventional and Cardiovascular Radiology, Houston, 2014 - Present
Member, The University of Texas MD Anderson Cancer Center, 2014 - 2023
Committee Member, NIH Radiology and Imaging Sciences MR Physicist Selection Committee, Washington DC, 2012 - 2012
Committee Member, NIH Clinical Center Ground Rounds Planning Committee, Washington DC, 2012 - 2014
Chair, NIH Clinical Center Cliniopathologic Ground Rounds Committee Meeting, Washington DC, 2012 - 2014
Committee Member, NIH Medical Research Scholars Program (MRSP) Board of Tutors, Washington DC, 2011 - 2014
Committee Member, American College of Radiology (ACR) Parameters and Standards Committee for Interventional Radiology, Reston, 2011 - Present
Committee Member, Society of Interventional Radiology (SIR) Interventional Oncology Service Line, Fairfax, 2009 - 2014
Committee Member, NIH Radiology and Imaging Sciences Dept PACS/RIS Improvement Committee, Washington DC, 2009 - 2014
Chief Resident, Massachusetts General Hospital, Boston, MA, 2004 - 2005
Institutional Committee Activities
Member, Genitourinary Medical Oncology Chair Search Committee, 2024 - 2024
Chair, Promotion and Tenure Committee, Clinical T/TT Faculty, (PTC-C), 2023 - 2024
Vice Chair, Promotion and Tenure Committee (PTC), 2023 - 2024
Member, Promotion and Tenure Committee, 2022 - 2023
Member, MDACC Faculty Recruitment Panel (FRP), 2022 - Present
Member, Advisory Council of Clinical Research Leaders (ACCRL), 2021 - 2024
Member, PSMA PET/MRI Review Committee, 2020 - Present
Member, Abdominal Imaging Fellowship Selection Committee, 2020 - Present
Member, Small Animal Imaging Facility (SAIF) Internal Advisory Committee, 2019 - Present
Member, Division of Diagnostic Imaging MRI Advisory Subcommittee, 2018 - Present
Section of Abdominal Imaging, Dept. of Diagnostic Radiology, Division of Diagnostic Imaging, Co-Chair, 2018 - 2018
Diagnostic Imaging Clinical Research Committee (DICRC), Chair, 2018 - Present
Diagnostic Imaging Representative, Acute and Critical Care Services Subcommittee of the Medical Staff, 2017 - Present
Member, Department of Diagnostic Radiology Abdominal Imaging Section Chief Search Committee, 2017 - 2018
Planning Committee for 2018 Cancer Imaging and Intervention Conference, Course Director, 2017 - 2018
Director, Research Search Committee, Department of Diagnostic Radiology, 2017 - 2018
Member, Dept. of Imaging Physics Residency Program Steering Committee, 2016 - Present
Member, Division of Diagnostic Imaging Research Trainee Symposium Planning Committee Meeting, 2016 - Present
Member, Dept. of Diagnostic Radiology PET/MRI Organization Committee, 2016 - 2018
Member, Division of Diagnostic Imaging Research Functional Committee, 2015 - Present
Director, Research Search Committee, 2015 - 2016
Honors & Awards
| 2022 | Fellow, American College of Radiology |
| 2022 | Fellow, Society for Abdominal Radiology |
| 2022 | Finalist, Radiation Oncology Strategic Initiatives Program Shark Tank Competition |
| 2021 | American Board of Radiology Volunteer Service Award, American Board of Radiology |
| 2020 | University of Texas MD Anderson Cancer Center President’s Recognition of Faculty Excellence Award in Research Excellence, MD Anderson Cancer Center |
| 2019 | Member, Academy Council, the Academy for Radiology & Biomedical Imaging Research |
| 2018 - 2024 | The University of Texas MD Anderson Cancer Center Support Grant (CCSG) Imaging-Driven Biology and Therapeutic (IDBT) Program, MD Anderson Cancer Center |
| 2014 - 2015 | 2014 Radiology Editor's Recognition Award |
| 2014 | Fellow, Society of Interventional Radiology |
| 2013 | Society of Interventional Radiology (SIR) 2013 Leadership Development Academy |
| 2010 | Clinical Trial Study Co-Chair for "MRgHIFU systems for effective treatment of uterine fibroids and cancer" |
| 2010 | NIH Clinical Center Director’s Award, National Institutes of Health |
| 2004 - 2005 | Chief Resident, Dept. of Diagnostic Radiology, Massachusetts General Hospital |
| 1997 - 1998 | Ebert Community Service Award, Harvard Medical School |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Hasanov E, Flynt L, Tidwell RS, Hwang H, Brooks R, Wood LM, Solley T, Syed M, Venkatesan AM, Jonasch E. STARLITE 1: Phase 1b/2 Study of Combined (177)Lu-Girentuximab plus Cabozantinib and Nivolumab in Treatment-naive Patients with Advanced Clear-cell Renal Cell Carcinoma. Eur Urol Focus, 2025. e-Pub 2025. PMID: 40288950.
- Seo, A, Xiao, W, Gjyshi, O, Court, K, Wei, P, Swanson, D, Napravnik, TC, Grippin, A, Venkatesan, AM, Jacobsen, MC, Fuentes, DA, Lynn, EJ, Sammouri, J, Jhingran, A, Joyner, MM, Lin, LL, Colbert, LE, Gillison, M, Klopp, AH. Human Papilloma Virus Circulating Cell-Free DNA Kinetics in Patients with Cervical Cancer Undergoing Definitive Chemoradiation. Clinical Cancer Research 31(4):697-706, 2025. e-Pub 2025. PMID: 39680029.
- Campbell MT, Shah AY, Msaouel P, Tannir NM, Siefker-Radtke AO, Kamat AM, Navai N, Dinney CPN, Rao P, Guo CC, Sheth RA, Venkatesan AM, Tidwell RS, Yadav SS, Gu A, Chen H, Macaluso M, Duan F, Basu S, Jindal S, Sharma P. A Pilot Study of the CD38 Antagonist Daratumumab in Patients with Metastatic Renal Cell Carcinoma or Muscle-Invasive Bladder Cancer. Cancer Res Commun 4(9):2444-2453, 2024. e-Pub 2024. PMID: 39207194.
- Nougaret S, Lambregts DMJ, Beets GL, Beets-Tan RGH, Blomqvist L, Burling D, Denost Q, Gambacorta MA, Gui B, Klopp A, Lakhman Y, Maturen KE, Manfredi R, Petkovska I, Russo L, Shinagare AB, Stephenson JA, Tolan D, Venkatesan AM, Quyn AJ, Forstner R. Imaging in pelvic exenteration-a multidisciplinary practice guide from the ESGAR-SAR-ESUR-PelvEx collaborative group. Eur Radiol, 2024. e-Pub 2024. PMID: 39181949.
- Expert Panel on GYN, Imaging OB, Shinagare AB, Burk KS, Kilcoyne A, Akin EA, Chuang L, Hindman NM, Huang C, Rauch GM, Small W, Stein EB, Venkatesan AM, Kang SK. ACR Appropriateness Criteria® Pretreatment Evaluation and Follow-Up of Invasive Cancer of the Cervix: 2023 Update. J Am Coll Radiol 21(6S):S249-S267, 2024. e-Pub 2024. PMID: 38823948.
- Wang, L, Ding, Y, Bruno, TL, Stafford, RJ, Lin, E, Bathala, TK, Sanders, JW, Ning, M, Ma, J, Klopp, AH, Venkatesan, AM, Wang, J, Martirosyan, KS, Frank, SJ. A Novel Positive-Contrast Magnetic Resonance Imaging Line Marker for High-Dose-Rate (HDR) MRI-Assisted Radiosurgery (MARS). Cancers 16(10), 2024. e-Pub 2024. PMID: 38792000.
- Sammouri J, Venkatesan AM, Lin LL, Jhingran A, Klopp AH, Joyner MM, Eifel PJ, Colbert LE. Management and long-term clinical outcomes of patients with stage IVA cervical cancer with bladder involvement. Gynecol Oncol 180:24-34, 2024. e-Pub 2024. PMID: 38041900.
- Curtin BF, Hill KL, Bhattacharya S, Powers A, Venkatesan A, Bagi P, Joyal E, Alimchandani M, Goldbach-Mansky R, Grayson P, Quezado M, Sibley C, Heller T. Clinical, Endoscopic, and Histopathologic Gastrointestinal Disease in an American Cohort With Behçet's Disease. Clin Transl Gastroenterol 14(8):e00591, 2023. e-Pub 2023. PMID: 37114910.
- Venkatesan AM. Imaging of Gynecologic Malignancy: The Current State-of-the-Art. Radiol Clin North Am 61(4):xv, 2023. e-Pub 2023. PMID: 37169436.
- Mayo CS, Feng MU, Brock KK, Kudner R, Balter P, Buchsbaum JC, Caissie A, Covington E, Daugherty EC, Dekker AL, Fuller CD, Hallstrom AL, Hong DS, Hong JC, Kamran SC, Katsoulakis E, Kildea J, Krauze AV, Kruse JJ, McNutt T, Mierzwa M, Moreno A, Palta JR, Popple R, Purdie TG, Richardson S, Sharp GC, Shiraishi S, Tarbox L, Venkatesan AM, Witztum A, Woods KE, Yao J, Farahani K, Aneja S, Gabriel PE, Hadjiiski L, Ruan D, Siewerdsen JH, Bratt S, Casagni M, Chen S, Christodouleas J, DiDonato A, Hayman J, Kapoor R, Kravitz S, Sebastian S, Von Siebenthal M, Xiao Y. Operational Ontology for Oncology (O3) - A Professional Society Based, Multi-Stakeholder, Consensus Driven Informatics Standard Supporting Clinical and Research use of "Real -World" Data from Patients Treated for Cancer: Operational Ontology for Radiation Oncology. Int J Radiat Oncol Biol Phys. e-Pub 2023. PMID: 37244628.
- Sanders JW, Tang C, Kudchadker RJ, Venkatesan AM, Mok H, Hanania AN, Thames HD, Bruno TL, Starks C, Santiago E, Cunningham M, Frank SJ. Uncertainty in magnetic resonance imaging-based prostate postimplant dosimetry: Results of a 10-person human observer study, and comparisons with automatic postimplant dosimetry. Brachytherapy 22(6):822-832, 2023. e-Pub 2023. PMID: 37716820.
- Jacobsen MC, Rigaud B, Simiele SJ, Rauch GM, Ning MS, Vedam S, Klopp AH, Stafford RJ, Brock KK, Venkatesan AM. Feasibility of quantitative diffusion-weighted imaging during intra-procedural MRI-guided brachytherapy of locally advanced cervical and vaginal cancers. Brachytherapy 22(6):736-745, 2023. e-Pub 2023. PMID: 37612174.
- Wu F, Chen PM, Gardinier TC, Turker MZ, Venkatesan AM, Patel V, Khor T, Bradbury MS, Wiesner UB, Adams GP, Germano G, Chen F, Ma K. Ultrasmall Folate Receptor Alpha Targeted Enzymatically Cleavable Silica Nanoparticle Drug Conjugates Augment Penetration and Therapeutic Efficacy in Models of Cancer. ACS Nano 16(12):20021-20033, 2022. e-Pub 2022. PMID: 36264003.
- Sherertz T, Jhingran A, Biagioli M, Gaffney D, Elshaikh M, Coleman RL, Harkenrider M, Kidd EA, Jolly S, Yashar C, Portelance L, Wahl A, Venkatesan A, Li L, Small W, Society AR. Executive summary of the American Radium Society appropriate use criteria for management of uterine clear cell and serous carcinomas. Int J Gynecol Cancer 32(12):1549-1554, 2022. e-Pub 2022. PMID: 36423958.
- Jacobsen MC, Beriwal S, Dyer BA, Klopp AH, Lee SI, McGinnis GJ, Robbins JB, Rauch GM, Sadowski EA, Simiele SJ, Stafford RJ, Taunk NK, Yashar CM, Venkatesan AM. Contemporary image-guided cervical cancer brachytherapy: Consensus imaging recommendations from the Society of Abdominal Radiology and the American Brachytherapy Society. Brachytherapy 21(4):369-388, 2022. e-Pub 2022. PMID: 35725550.
- Shinagare, AB, Sadowski, EA, Park, H, Brook, O, Forstner, R, Wallace, SA, Horowitz, JM, Horowitz, NS, Javitt, MC, Jha, P, Kido, A, Lakhman, Y, Lee, SI, Manganaro, L, Maturen, KE, Nougaret, S, Poder, L, Rauch, GM, Reinhold, C, Sala, E, Thomassin-Naggara, I, Vargas, HA, Venkatesan, AM, Nikolic, O, Rockall, AG. Ovarian cancer reporting lexicon for computed tomography (CT) and magnetic resonance (MR) imaging developed by the SAR Uterine and Ovarian Cancer Disease-Focused Panel and the ESUR Female Pelvic Imaging Working Group. European Radiology 32(5):3220-3235, 2022. e-Pub 2022. PMID: 34846566.
- De B, Venkatesan AM, Msaouel P, Ghia AJ, Li J, Yeboa DN, Nguyen QN, Bishop AJ, Jonasch E, Shah AY, Campbell MT, Wang J, Zurita-Saavedra AJ, Karam JA, Wood CG, Matin SF, Tannir NM, Tang C. Definitive radiotherapy for extracranial oligoprogressive metastatic renal cell carcinoma as a strategy to defer systemic therapy escalation 129(5):610-320, 2022. e-Pub 2022. PMID: 34228889.
- Sanders JW, Mok H, Hanania AN, Venkatesan AM, Tang C, Bruno TL, Thames HD, Kudchadker RJ, Frank SJ. Computer-aided segmentation on MRI for prostate radiotherapy, part II: Comparing human and computer observer populations and the influence of annotator variability on algorithm variability. Radiother Oncol 169:132-139, 2022. e-Pub 2022. PMID: 34979213.
- Sanders JW, Kudchadker RJ, Tang C, Mok H, Venkatesan AM, Thames HD, Frank SJ. Prospective Evaluation of Prostate and Organs at Risk Segmentation Software for MRI-based Prostate Radiation Therapy. Radiol Artif Intell 4(2):e210151, 2022. e-Pub 2022. PMID: 35391775.
- Treviño M, Birdsong G, Carrigan A, Choyke P, Drew T, Eckstein M, Fernandez A, Gallas BD, Giger M, Hewitt SM, Horowitz TS, Jiang YV, Kudrick B, Martinez-Conde S, Mitroff S, Nebeling L, Saltz J, Samuelson F, Seltzer SE, Shabestari B, Shankar L, Siegel E, Tilkin M, Trueblood JS, Van Dyke AL, Venkatesan AM, Whitney D, Wolfe JM. Advancing Research on Medical Image Perception by Strengthening Multidisciplinary Collaboration. JNCI Cancer Spectr 6(1), 2022. e-Pub 2022. PMID: 35699495.
- Sanders JW, Mok H, Hanania AN, Venkatesan AM, Tang C, Bruno TL, Thames HD, Kudchadker RJ, Frank SJ. Computer-aided segmentation on MRI for prostate radiotherapy, Part I: Quantifying human interobserver variability of the prostate and organs at risk and its impact on radiation dosimetry. Radiother Oncol. e-Pub 2021. PMID: 34921895.
- Expert Panel on GYN, Imaging OB, Kilcoyne A, Gottumukkala RV, Kang SK, Akin EA, Hauck C, Hindman NM, Huang C, Khanna N, Paspulati R, Rauch GM, Said T, Shinagare AB, Stein EB, Venkatesan AM, Maturen KE. ACR Appropriateness Criteria® Staging and Follow-up of Primary Vaginal Cancer. J Am Coll Radiol 18(11S):S442-S455, 2021. e-Pub 2021. PMID: 34794599.
- Sen A, Troncoso P, Venkatesan AM, Pagel MD, Nijkamp JA, He Y, Lesage AC, Woodland M, Brock KK. Correlation of in-vivo imaging with histopathology: A review 144(109964), 2021. e-Pub 2021. PMID: 34619617.
- Kilcoyne A, Gottumukkala RV, Kang SK, Akin EA, Hauck C, Hindman NM, Huang C, Khanna N, Paspulati R, Rauch GM, Said T, Shinagare AB, Stein EB, Venkatesan AM, Maturen KE. ACR Appropriateness Criteria Staging and Follow-up of Primary Vaginal Cancer. Expert Panel on GYN and OB Imaging, J Am Coll Radiol 18(11S):S442-S455, 2021. e-Pub 2021. PMID: 34794599.
- Bhattacharya S, Koethe Y, Ling A, Kamal N, Khangura S, Alimchandani M, Quezado MM, Zerbe CS, Malech HL, Gallin JI, Holland SM, Heller T, Jones E, Venkatesan AM. Gastrointestinal Computed Tomography Findings in Chronic Granulomatous Disease with Subgroup Clinicopathologic Analysis. Dig Dis Sci. e-Pub 2021. PMID: 33934254.
- Urological Imaging EPO, Allen BC, Oto A, Akin O, Alexander LF, Froemming AT, Fulgham PF, Halpern DJ, Gettle LM, Maranchie JK, Patel BN, Patlas MN, Schieda N, Solanki A, Turkbey IB, Venkatesan AM, Yoo DC, Lockhart ME. ACR Appropriateness Criteria® Post-Treatment Surveillance of Bladder Cancer: 2021 Update. J Am Coll Radiol 18(5S):S126-S138, 2021. e-Pub 2021. PMID: 33958107.
- Rigaud B, Anderson BM, Yu ZH, Gobeli M, Cazoulat G, Söderberg J, Samuelsson E, Lidberg D, Ward C, Taku N, Cardenas C, Rhee DJ, Venkatesan AM, Peterson CB, Court L, Svensson S, Löfman F, Klopp AH, Brock KK. Automatic Segmentation Using Deep Learning to Enable Online Dose Optimization During Adaptive Radiation Therapy of Cervical Cancer. Int J Radiat Oncol Biol Phys 109(4):1096-1110, 2021. e-Pub 2021. PMID: 33181248.
- McGregor BA, Campbell MT, Xie W, Farah S, Bilen MA, Schmidt AL, Sonpavde GP, Kilbridge KL, Choudhury AD, Mortazavi A, Shah AY, Venkatesan AM, Bubley GJ, Siefker-Radtke AO, McKay RR, Choueiri TK. Results of a multicenter, phase 2 study of nivolumab and ipilimumab for patients with advanced rare genitourinary malignancies. Cancer 127(6):840-849, 2021. e-Pub 2021. PMID: 33216356.
- Gregg JR, Borregales LD, Choi H, Lozano M, McRae SE, Venkatesan AM, Davis JW, Nogueras-Gonzalez GM, Pisters LL, Ward JF. Prospective trial of regional (hockey-stick) prostate cryoablation: oncologic and quality of life outcomes. World J Urol. e-Pub 2021. PMID: 33454813.
- Venkatesan AM, Mudairu-Dawodu E, Duran C, Stafford RJ, Yan Y, Wei W, Kundra V. Detecting recurrent prostate Cancer using multiparametric MRI, influence of PSA and Gleason grade. Cancer Imaging 21(1):3, 2021. e-Pub 2021. PMID: 33407861.
- Venkatesan AM, Oto A, Allen BC, Akin O, Alexander LF, Chong J, Froemming AT, Fulgham PF, Goldfarb S, Gettle LM, Maranchie JK, Patel BN, Schieda N, Schuster DM, Turkbey IB, Lockhart ME. ACR Appropriateness Criteria(R) Recurrent Lower Urinary Tract Infections in Females. J Am Coll Radiol 17(11S):S487-S496, 2020. e-Pub 2020. PMID: 33153559.
- Sanders JW, Venkatesan AM, Levitt CA, Bathala T, Kudchadker RJ, Tang C, Bruno TL, Starks C, Santiago E, Wells M, Weaver CP, Ma J, Frank SJ. Fully Balanced SSFP Without an Endorectal Coil for Postimplant QA of MRI-Assisted Radiosurgery (MARS) of Prostate Cancer: A Prospective Study. Int J Radiat Oncol Biol Phys. e-Pub 2020. PMID: 32980498.
- Sanders JW, Lewis GD, Thames HD, Kudchadker RJ, Venkatesan AM, Bruno TL, Ma J, Pagel MD, Frank SJ. Machine Segmentation of Pelvic Anatomy in MRI-Assisted Radiosurgery (MARS) for Prostate Cancer Brachytherapy. Int J Radiat Oncol Biol Phys. e-Pub 2020. PMID: 32634543.
- Bathala TK, Venkatesan AM, Ma J, Bhosale P, Wei W, Kudchadker RJ, Wang J, Anscher MS, Tang C, Bruno TL, Frank SJ, Szklaruk J. Quality comparison between three-dimensional T2-weighted SPACE and two-dimensional T2-weighted turbo spin echo magnetic resonance images for the brachytherapy planning evaluation of prostate and periprostatic anatomy. Brachytherapy. e-Pub 2020. PMID: 32402544.
- Ning MS, Vedam S, Ma J, Stafford RJ, Bruno TL, Cunningham M, Starks C, Lawyer A, Venkatesan AM, Wang L, Wang J, Olivieri ND, Guzman AB, Incalcaterra JR, Thaker NG, Joyner MM, Lin LL, Jhingran A, Eifel PJ, Klopp AH. Clinical utility and value contribution of an MRI-positive line marker for image-guided brachytherapy in gynecologic malignancies. Brachytherapy 19(3):305-315, 2020. e-Pub 2020. PMID: 32265119.
- Rigaud B, Cazoulat G, Vedam S, Venkatesan AM, Peterson CB, Taku N, Klopp AH, Brock KK. Modeling Complex Deformations of the Sigmoid Colon Between External Beam Radiation Therapy and Brachytherapy Images of Cervical Cancer. Int J Radiat Oncol Biol Phys 106(5):1084-1094, 2020. e-Pub 2020. PMID: 32029345.
- Gramann AK, Venkatesan AM, Guerin M, Ceol CJ. Regulation of zebrafish melanocyte development by ligand-dependent BMP signaling. Elife 8, 2019. e-Pub 2019. PMID: 31868592.
- Urologic Imaging EPO, Allen BC, Oto A, Akin O, Alexander LF, Chong J, Froemming AT, Fulgham PF, Lloyd S, Maranchie JK, Mody RN, Patel BN, Schieda N, Turkbey IB, Vapiwala N, Venkatesan AM, Wang CL, Yoo DC, Lockhart ME. ACR Appropriateness Criteria® Post-Treatment Surveillance of Bladder Cancer. J Am Coll Radiol 16(11S):S417-S427, 2019. e-Pub 2019. PMID: 31685109.
- Urological Imaging EPO, Alexander LF, Oto A, Allen BC, Akin O, Chong J, Froemming AT, Fulgham PF, Goldfarb S, Maranchie JK, Mody RN, Patel BN, Schieda N, Schuster DM, Turkbey IB, Venkatesan AM, Wang CL, Lockhart ME. ACR Appropriateness Criteria® Lower Urinary Tract Symptoms-Suspicion of Benign Prostatic Hyperplasia. J Am Coll Radiol 16(11S):S378-S383, 2019. e-Pub 2019. PMID: 31685105.
- Urological Imaging EPO, Heller MT, Oto A, Allen BC, Akin O, Alexander LF, Chong J, Froemming AT, Fulgham PF, Mackenzie DC, Maranchie JK, Mody RN, Patel BN, Schieda N, Turkbey IB, Venkatesan AM, Wang CL, Lockhart ME. ACR Appropriateness Criteria® Penetrating Trauma-Lower Abdomen and Pelvis. J Am Coll Radiol 16(11S):S392-S398, 2019. e-Pub 2019. PMID: 31685107.
- Ning MS, Venkatesan AM, Stafford RJ, Bui TP, Carlson R, Bailard NS, Vedam S, Davis R, Olivieri ND, Guzman AB, Incalcaterra JR, McKelvey FA, Thaker NG, Rauch GM, Tang C, Frank SJ, Joyner MM, Lin LL, Jhingran A, Eifel PJ, Klopp AH. Developing an intraoperative 3T MRI-guided brachytherapy program within a diagnostic imaging suite: Methods, process workflow, and value-based analysis. Brachytherapy. e-Pub 2019. PMID: 31786169.
- Venkatesan AM, Menias CO, Jones KM, Rauch GM, Stafford RJ, Klopp AH. MRI for Radiation Therapy Planning in Human Papillomavirus-associated Gynecologic Cancers. Radiographics 39(5):1476-1500, 2019. e-Pub 2019. PMID: 31498740.
- Sanders JW, Fletcher JR, Frank SJ, Liu HL, Johnson JM, Zhou Z, Chen HS, Venkatesan AM, Kudchadker RJ, Pagel MD, Ma J. Deep learning application engine (DLAE): Development and integration of deep learning algorithms in medical imaging. SoftwareX 10, 2019. e-Pub 2019. PMID: 34113706.
- Expert Panel on Urological Imaging:Wang CL, Aryal B, Oto A, Allen BC, Akin O, Alexander LF, Bardo DME, Chong J, Froemming AT, Fulgham PF, Heller MT, Maranchie JK, Mody RN, Patel BN, Schieda N, Turkbey IB, Venkatesan AM, Yoo DC, Lockhart ME. ACR Appropriateness Criteria® Acute Onset of Scrotal Pain-Without Trauma, Without Antecedent Mass. J Am Coll Radiol 16(5S):S38-S43, 2019. e-Pub 2019. PMID: 31054757.
- Petros FG, Venkatesan AM, Kaya D, Ng CS, Fellman BM, Karam JA, Wood CG, Matin SF. Conditional survival of patients with small renal masses undergoing active surveillance. BJU Int 123(3):447-455, 2019. e-Pub 2019. PMID: 30007044.
- Rigaud B, Klopp A, Vedam S, Venkatesan AM, Taku N, Simon A, Haigron P, de Crevoisier R, Brock KK, Cazoulat G. Deformable image registration for dose mapping between external beam radiotherapy and brachytherapy images of cervical cancer. Phys Med Biol, 2019. e-Pub 2019. PMID: 30913542.
- Levy EB, Peer C, Sissung TM, Venkatesan AM, Pandalai P, Greten T, Hughes MS, Garcia C, Peretti J, Figg W, Lewis A, Wood B. Pilot Study Comparing Systemic and Tissue Pharmacokinetics of Irinotecan and Metabolites after Hepatic Drug-Eluting Chemoembolization. J Vasc Interv Radiol 30(1):19-22, 2019. e-Pub 2019. PMID: 30527657.
- Chehab MA, Thakor AS, Tulin-Silver S, Connolly BL, Cahill AM, Ward TJ, Padia SA, Kohi MP, Midia M, Chaudry G, Gemmete JJ, Mitchell JW, Brody L, Crowley JJ, Heran MKS, Weinstein JL, Nikolic B, Dariushnia SR, Tam AL, Venkatesan AM. Adult and pediatric antibiotic prophylaxis during vascular and IR procedures: a Society of Interventional Radiology practice parameter update endorsed by the Cardiovascular and Interventional Radiological Society of Europe and the Canadian Association for Interventional Radiology. J Vasc Interv Radiol 29(11):1483-1501.e2, 2018. e-Pub 2018. PMID: 30274857.
- Campbell MT, Bilen MA, Shah AY, Lemke E, Jonasch E, Venkatesan AM, Altinmakas E, Duran C, Msaouel P, Tannir NM. Cabozantinib for the treatment of patients with metastatic non-clear cell renal cell carcinoma: a retrospective analysis. Eur J Cancer 104:188-194. e-Pub 2018. PMID: 30380460.
- Sanders J, Frank S, Bathala T, Venkatesan AM, Anscher M, Tang C, Bruno T, Wei W, Ma J. Compressed sensing for prostate cancer brachytherapy post-implant MRI without an endorectal coil. Brachytherapy 17(4):S72-S73, 2018. e-Pub 2018.
- Sanders JW, Song H, Frank SJ, Bathala T, Venkatesan AM, Anscher M, Tang C, Bruno TL, Wei W, Ma J. Parallel imaging compressed sensing for accelerated imaging and improved signal-to-noise ratio in MRI-based postimplant dosimetry of prostate brachytherapy. Brachytherapy. e-Pub 2018. PMID: 29880449.
- Froemming AT, Verma S, Eberhardt SC, Oto A, Alexander LF, Allen BC, Coakley FV, Davis BJ, Fulgham PF, Hosseinzadeh K, Porter C, Sahni VA, Schuster DM, Showalter TN, Venkatesan AM, Wang CL, Remer EM. ACR appropriateness criteria® post-treatment follow-up prostate cancer. J Am Coll Radiol 15(5S):S132-S149, 2018. e-Pub 2018. PMID: 29724417.
- van der Pol CB, Sahni VA, Eberhardt SC, Oto A, Akin O, Alexander LF, Allen BC, Coakley FV, Froemming AT, Fulgham PF, Hosseinzadeh K, Maranchie JK, Mody RN, Schieda N, Schuster DM, Venkatesan AM, Wang CL, Lockhart ME. ACR appropriateness criteria® pretreatment staging of muscle-invasive bladder cancer. J Am Coll Radiol 15(5S):S150-S159, 2018. e-Pub 2018. PMID: 29724418.
- Jawed I, Velarde M, Därr R, Wolf KI, Adams K, Venkatesan AM, Balasubramaniam S, Poruchynsky MS, Reynolds JC, Pacak K, Fojo T. Continued tumor reduction of metastatic Pheochromocytoma/Paraganglioma harboring succinate dehydrogenase subunit B mutations with cyclical chemotherapy. Cell Mol Neurobiol. e-Pub 2018. PMID: 29623478.
- Venkatesan AM, Vyas R, Gramann AK, Dresser K, Gujja S, Bhatnagar S, Chhangawala S, Gomes CBF, Xi HS, Lian CG, Houvras Y, Edwards YJK, Deng A, Green M, Ceol CJ. Ligand-activated BMP signaling inhibits cell differentiation and death to promote melanoma. J Clin Invest 128(1):294-308, 2018. e-Pub 2018. PMID: 29202482.
- Sun CY, Walker CM, Michel KA, Venkatesan AM, Lai SY, Bankson JA. Influence of parameter accuracy on pharmacokinetic analysis of hyperpolarized pyruvate. Magn Reson Med. e-Pub 2017. PMID: 29090487.
- Stork G, Yamashita A, Hanson RM, Phan L, Phillips E, Dube D, Bos PH, Clark AJ, Gough M, Greenlee ML, Jiang Y, Jones K, Kitamura M, Leonard J, Liu T, Parsons PJ, Venkatesan AM. Synthetic Study toward Total Synthesis of (+/-)-Germine: Synthesis of (+/-)-4-Methylenegermine. Org Lett 19(19):5150-5153, 2017. e-Pub 2017. PMID: 28876074.
- Arora M, Bagi P, Strongin A, Heimall J, Zhao X, Lawrence MG, Trivedi A, Henderson C, Hsu A, Quezado M, Kleiner DE, Venkatesan AM, Holland SM, Freeman AF, Heller T. Gastrointestinal manifestations of STAT3-deficient hyper-IgE syndrome. J Clin Immunol 37(7):695-700, 2017. e-Pub 2017. PMID: 28803389.
- Yamashita S, Venkatesan AM, Mizuno T, Aloia TA, Chun YS, Lee JE, Vauthey JN, Conrad C. Remnant liver Ischemia as a prognostic factor for cancer-specific survival after resection of colorectal liver metastases. JAMA Surg 152(10):e172986, 2017. e-Pub 2017. PMID: 28854316.
- Coakley FV, Oto A, Alexander LF, Allen BC, Davis BJ, Froemming AT, Fulgham PF, Hosseinzadeh K, Porter C, Sahni VA, Schuster DM, Showalter TN, Venkatesan AM, Verma S, Wang CL, Remer EM, Eberhardt SC. ACR appropriateness criteria(®) prostate cancer-pretreatment detection, surveillance, and staging. J Am Coll Radiol 14(5S):S245-S257, 2017. e-Pub 2017. PMID: 28473080.
- Duffy AG, Ulahannan SV, Makorova-Rusher O, Rahma O, Wedemeyer H, Pratt D, Davis JL, Hughes MS, Heller T, ElGindi M, Uppala A, Korangy F, Kleiner DE, Figg WD, Venzon D, Steinberg SM, Venkatesan AM, Krishnasamy V, Abi-Jaoudeh N, Levy E, Wood BJ, Greten TF. Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma. J Hepatol 66(3):545-551, 2017. e-Pub 2017. PMID: 27816492.
- Venkatesan AM, Stafford RJ, Duran C, Soni PD, Berlin A, McLaughlin PW. Prostate MRI for brachytherapists: anatomy and technique. Brachytherapy. e-Pub 2017. PMID: 28237429.
- Ma J, Moerland MA, Venkatesan AM, Bathala TK, Kudchadker RJ, Brock KK, Frank SJ. Pulse sequence considerations for simulation and postimplant dosimetry of prostate brachytherapy. Brachytherapy. e-Pub 2017. PMID: 28063817.
- Soni PD, Berlin A, Venkatesan AM, McLaughlin PW. Magnetic resonance imaging-guided functional anatomy approach to prostate brachytherapy. Brachytherapy. e-Pub 2016. PMID: 28040380.
- Payabyab EC, Balasubramaniam S, Edgerly M, Velarde M, Merino MJ, Venkatesan AM, Leuva H, Litman T, Bates SE, Fojo T. Adrenocortical cancer: a molecularly complex disease where surgery matters. Clin Cancer Res 22(20):4989-5000, 2016. e-Pub 2016. PMID: 27742785.
- Assadipour Y, Azoury SC, Schaub NN, Hong Y, Eil R, Inchauste SM, Steinberg SM, Venkatesan AM, Libutti SK, Hughes MS. Significance of preoperative radiographic pancreatic density in predicting pancreatic fistula after surgery for pancreatic neuroendocrine tumors. Am J Surg 212(1), 2016. e-Pub 2016. PMID: 26782807.
- Rajagopal M, Venkatesan AM. Image fusion and navigation platforms for percutaneous image-guided interventions. Abdom Radiol (NY) 41(4):620-8, 2016. e-Pub 2016. PMID: 26826086.
- Hughes MS, Azoury SC, Assadipour Y, Straughan DM, Trivedi AN, Lim RM, Joy G, Voellinger MT, Tang DM, Venkatesan AM, Chen CC, Louie A, Quezado MM, Forbes J, Wank SA. Prospective evaluation and treatment of familial carcinoid small intestine neuroendocrine tumors (SI-NETs). Surgery 159(1):350-7, 2016. e-Pub 2016. PMID: 26454678.
- Merchant MS, Bernstein D, Amoako M, Baird K, Fleisher TA, Morre M, Steinberg SM, Sabatino M, Stroncek DF, Venkatesan AM, Wood BJ, Wright M, Zhang H, Mackall CL. Adjuvant immunotherapy to improve outcome in high risk pediatric sarcomas. Clin Cancer Res. e-Pub 2016. PMID: 26823601.
- Gaba RC, Baerlocher MO, Nikolic B, Venkatesan AM, Lewandowski RJ. Clinical and imaging follow-up practices after transarterial therapy for primary and secondary hepatic malignancies: results of an online survey. Acad Radiol 22(12):1510-5, 2015. e-Pub 2015. PMID: 26432072.
- Mikhail AS, Partanan A, Yarmolenko P, Venkatesan AM, Wood BJ. MR-guided drug delivery. Magn Reson Imaging Clin In Am 23(4):643-655, 2015. e-Pub 2015. PMID: 26499281.
- Klepac Pulanic T, Venkatesan AM, Segars J, Sokka S, Wood BJ, Stratton P. Vaginal pessary for uterine repositioning during high-intensity focused ultrasound ablation of uterine leiomyomas. Gynecol Obstet Invest. e-Pub 2015. PMID: 26584482.
- Duffy AG, Ulahannan SV, Cao L, Rahma OE, Makarova-Rusher OV, Kleiner DE, Fioravanti S, Walker M, Carey S, Yu Y, Venkatesan AM, Turkbey B, Choyke P, Trepel J, Bollen KC, Steinberg SM, Figg WD, Greten TF. A phase II study of TRC105 in patients with hepatocellular carcinoma who have progressed on sorafenib. United European Gastroenterol Journal 3(5):453-61, 2015. e-Pub 2015. PMID: 26535124.
- Sei Y, Zhao X, Forbes J, Szymczak S, Li Q, Trivedi A, Voellinger M, Joy G, Feng J, Whatley M, Jones MS, Harper UL, Marx SJ, Venkatesan AM, Chandrasekharappa SC, Raffeld M, Quezado MM, Louie A, Chen CC, Lim RM, Agarwala R, Schäffer AA, Hughes MS, Bailey-Wilson JE, Wank SA. A hereditary form of small intestinal carcinoid associated with a germline mutation in inositol polyphosphate multikinase. Gastroenterology. e-Pub 2015. PMID: 25865046.
- Abi-Jaoudeh N, Venkatesan AM, Van der Sterren W, Radaelli A, Carelsen B, Wood BJ. Clinical experience with cone-beam CT navigation for tumor ablation. J Vasc Interv Radiol 26(2):214-9, 2015. e-Pub 2015. PMID: 25645409.
- Dauer LT, Miller DL, Schueler B, Silberzweig J, Balter S, Bartal G, Chambers C, Collins JD, Damilakis J, Dixon RG, Victoria Marx M, Stecker MS, Vañó E, Venkatesan AM, Nikolic B, Radiology Safety SOI, Committee H, Cardiovascular, Practice Committee IRSOESO. Occupational radiation protection of pregnant or potentially pregnant workers in IR: a joint guideline of the Society of Interventional Radiology and the Cardiovascular and Interventional Radiological Society of Europe. J Vasc Interv Radiol 26(2):171-81, 2015. e-Pub 2015. PMID: 25645407.
- O'Sullivan C, Edgerly M, Velarde M, Wilkerson J, Venkatesan AM, Pittaluga S, Yang SX, Nguyen D, Balasubramaniam S, Fojo T. The VEGF inhibitor axitinib has limited effectiveness as a therapy for adrenocortical cancer. J Clin Endocrinol Metab 99(4):1291-7, 2014. e-Pub 2014. PMID: 24423320.
- Koethe Y, Xu S, Velusamy G, Wood BJ, Venkatesan AM. Accuracy and efficacy of percutaneous biopsy and ablation using robotic assistance under computed tomography guidance: a phantom study. Eur Radiol 24(3):723-30, 2014. e-Pub 2014. PMID: 24220755.
- Partanen A, Yerram NK, Trivedi H, Dreher MR, Oila J, Hoang AN, Volkin D, Nix J, Turkbey B, Bernardo M, Haines DC, Benjamin CJ, Linehan WM, Choyke P, Wood BJ, Ehnholm GJ, Venkatesan AM, Pinto PA. Magnetic resonance imaging (MRI)-guided transurethral ultrasound therapy of the prostate: a preclinical study with radiological and pathological correlation using customised MRI-based moulds. BJU Int 112(4):508-16, 2013. e-Pub 2013. PMID: 23746198.
- Azad N, Yu M, Davidson B, Choyke P, Chen CC, Wood BJ, Venkatesan AM, Henning R, Calvo K, Minasian L, Edelman DC, Meltzer P, Steinberg SM, Annunziata CM, Kohn EC. Translational predictive biomarker analysis of the phase 1b sorafenib and bevacizumab study expansion cohort. Mol Cell Proteomics 12(6):1621-31, 2013. e-Pub 2013. PMID: 23449826.
- Venkatesan AM, Partanen A, Pulanic TK, Dreher MR, Fischer J, Zurawin RK, Muthupillai R, Sokka S, Nieminen HJ, Sinaii N, Merino M, Wood BJ, Stratton P. Magnetic resonance imaging-guided volumetric ablation of symptomatic leiomyomata: correlation of imaging with histology. J Vasc Interv Radiol 23(6):786-794.e4, 2012. e-Pub 2012. PMID: 22626269.
- Abi-Jaoudeh N, Mielekamp P, Noordhoek N, Venkatesan AM, Millo C, Radaelli A, Carelsen B, Wood BJ. Cone-beam computed tomography fusion and navigation for real-time positron emission tomography-guided biopsies and ablations: a feasibility study. J Vasc Interv Radiol 23(6):737-43, 2012. e-Pub 2012. PMID: 22494658.
- Dauer LT, Thornton RH, Miller DL, Damilakis J, Dixon RG, Marx MV, Schueler BA, Vañó E, Venkatesan AM, Bartal G, Tsetis D, Cardella JF, Radiology Safety SOI, Committee H, Cardiovascular, Practice Committee IRSOESO. Radiation management for interventions using fluoroscopic or computed tomographic guidance during pregnancy: a joint guideline of the Society of Interventional Radiology and the Cardiovascular and Interventional Radiological Society of Europe with Endorsement by the Canadian Interventional Radiology Association. J Vasc Interv Radiol 23(1):19-32, 2012. e-Pub 2012. PMID: 22112899.
- Kitano M, Millo C, Rahbari R, Herscovitch P, Gesuwan K, Webb RC, Venkatesan AM, Phan GQ, Hughes MS, Libutti SK, Nilubol N, Linehan WM, Kebebew E. Comparison of 6-18F-fluoro-L-DOPA, 18F-2-deoxy-D-glucose, CT, and MRI in patients with pancreatic neuroendocrine neoplasms with von Hippel-Lindau disease. Surgery 150(6):1122-8, 2011. e-Pub 2011. PMID: 22136831.
- Venkatesan AM, Trivedi H, Adams KT, Kebebew E, Pacak K, Hughes MS. Comparison of clinical and imaging features in succinate dehydrogenase-positive versus sporadic paragangliomas. Surgery 150(6):1186-93, 2011. e-Pub 2011. PMID: 22136839.
- Venkatesan AM, Kadoury S, Abi-Jaoudeh N, Levy EB, Maass-Moreno R, Krücker J, Dalal S, Xu S, Glossop N, Wood BJ. Real-time FDG PET guidance during biopsies and radiofrequency ablation using multimodality fusion with electromagnetic navigation. Radiology 260(3):848-56, 2011. e-Pub 2011. PMID: 21734159.
- Dehnhardt CM, Venkatesan AM, Chen Z, Delos-Santos E, Ayral-Kaloustian S, Brooijmans N, Yu K, Hollander I, Feldberg L, Lucas J, Mallon R. Identification of 2-oxatriazines as highly potent pan-PI3K/mTOR dual inhibitors. Bioorg Med Chem Lett 21(16):4773-8, 2011. e-Pub 2011. PMID: 21763134.
- Krücker J, Xu S, Venkatesan AM, Locklin JK, Amalou H, Glossop N, Wood BJ. Clinical utility of real-time fusion guidance for biopsy and ablation. J Vasc Interv Radiol 22(4):515-24, 2011. e-Pub 2011. PMID: 21354816.
- Kelly RJ, Draper D, Chen CC, Robey RW, Figg WD, Piekarz RL, Chen X, Gardner ER, Balis FM, Venkatesan AM, Steinberg SM, Fojo T, Bates SE. A pharmacodynamic study of docetaxel in combination with the P-glycoprotein antagonist tariquidar (XR9576) in patients with lung, ovarian, and cervical cancer. Clin Cancer Res 17(3):569-80, 2011. e-Pub 2011. PMID: 21081657.
- Venkatesan AM, Chen Z, dos Santos O, Dehnhardt C, Santos ED, Ayral-Kaloustian S, Mallon R, Hollander I, Feldberg L, Lucas J, Yu K, Chaudhary I, Mansour TS. PKI-179: an orally efficacious dual phosphatidylinositol-3-kinase (PI3K)/mammalian target of rapamycin (mTOR) inhibitor. Bioorg Med Chem Lett 20(19):5869-73, 2010. e-Pub 2010. PMID: 20797855.
- Venkatesan AM, Dehnhardt CM, Delos Santos E, Chen Z, Dos Santos O, Ayral-Kaloustian S, Khafizova G, Brooijmans N, Mallon R, Hollander I, Feldberg L, Lucas J, Yu K, Gibbons J, Abraham RT, Chaudhary I, Mansour TS. Bis(morpholino-1,3,5-triazine) derivatives: potent adenosine 5'-triphosphate competitive phosphatidylinositol-3-kinase/mammalian target of rapamycin inhibitors: discovery of compound 26 (PKI-587), a highly efficacious dual inhibitor. J Med Chem 53(6):2636-45, 2010. e-Pub 2010. PMID: 20166697.
- Chen Z, Venkatesan AM, Dos Santos O, Delos Santos E, Dehnhardt CM, Ayral-Kaloustian S, Ashcroft J, McDonald LA, Mansour TS. Stereoselective synthesis of an active metabolite of the potent PI3 kinase inhibitor PKI-179. J Org Chem 75(5):1643-51, 2010. e-Pub 2010. PMID: 20112997.
- Venkatesan AM, Locklin J, Lai EW, Adams KT, Fojo AT, Pacak K, Wood BJ. Radiofrequency ablation of metastatic pheochromocytoma. J Vasc Interv Radiol 20(11):1483-90, 2009. e-Pub 2009. PMID: 19875067.
- Kerkar SP, Kemp CD, Duffy A, Kammula US, Schrump DS, Kwong KF, Quezado M, Goldspiel BR, Venkatesan AM, Berger A, Walker M, Toomey MA, Steinberg SM, Giaccone G, Rosenberg SA, Avital I. The GYMSSA trial: a prospective randomized trial comparing gastrectomy, metastasectomy plus systemic therapy versus systemic therapy alone. Trials 10:121, 2009. e-Pub 2009. PMID: 20030854.
- Venkatesan AM, Shetty SK, Galdino GM, Davila DA, Lawrimore TA, Foster KM. The impact of professional turf battles on radiology resident education: perspectives from the class of 2005. Journal of the American College of Radiology 3:537-543, 2006. e-Pub 2006. PMID: 17412119.
- Venkatesan AM, Gervais DA, Mueller PR. Percutaneous radiofrequency thermal ablation of primary and metastatic hepatic tumors: Current concepts and review of the literature. Semin Intervent Radiol 23(1):73-84, 2006. e-Pub 2006. PMID: 21326722.
- Shetty SK, Venkatesan AM, Foster KM, Galdino GM, Lawrimore TM, Davila JA. The radiology class of 2005: the fellowship application process and perceptions of the NRMP fellowship match. J Am Coll Radiol 2(11):939-51, 2005. e-Pub 2005. PMID: 17411969.
- Shetty SK, Venkatesan AM, Foster KM, Galdino GM, Lawrimore TM, Davila JA. The radiology class of 2005: postresidency plans. J Am Coll Radiol 2(10):852-8, 2005. e-Pub 2005. PMID: 17411947.
- Venkatesan AM, Karmpaliotis D, Silverman ES. Neurogenic pulmonary edema following catastrophic subarachnoid hemorrhage: a case report and pathophysiologic review. J Intensive Care Med 16(5):236-242, 2001. e-Pub 2001.
- Glanz BI, Venkatesan AM, Schur PH, Lew RA, Khoshbin S. Prevalence of migraine in patients with systemic lupus erythematosus. Headache 41(3):285-9, 2001. e-Pub 2001. PMID: 11264689.
Invited Articles
- Venkatesan AM. Opportunities for Research, Education, and Training at the National Institutes of Health. Semin Intervent Radiol, 2015. e-Pub 2015. PMID: 26327752.
Manuals, Teaching Aids, Other Teaching Publications
- Liu H, Venkatesan AM, Chen H, Einstein S, Fahrenholtz S, MacLellan C, Nishino T, Reeve D, Stafford R, Walker C. Basic principles of nuclear magnetic resonance. RSNA/AAPM Online Physics Module, 2019.
Other Articles
- Nougaret S, Lambregts DMJ, Beets GL, Beets-Tan RGH, Blomqvist L, Burling D, Denost Q, Gambacorta MA, Gui B, Klopp A, Lakhman Y, Maturen KE, Manfredi R, Petkovska I, Russo L, Shinagare AB, Stephenson JA, Tolan D, Venkatesan AM, Quyn AJ, Forstner R Correction: Imaging in pelvic exenteration-a multidisciplinary practice guide from the ESGAR-SAR-ESUR-PelvEx collaborative group. Eur Radiol, 2025. PMID: 40063109.
- Avesani G, Bonatti M, Venkatesan AM, Nougaret S, Sala E RadioGraphics Update: 2023 FIGO Staging System for Endometrial Cancer. Radiographics 44(7):e240084, 2024. PMID: 38935549.
- Yankeelov TE, Hormuth DA, EABF L, Lorenzo G, Wu C, Okereke LC, Rauch GM, Venkatesan AM, Chung C Designing clinical trials for patients who are not average. iScience 27(1):108589, 2024. PMID: 38169893.
- Chehab M, Kouri BE, Miller MJ, Venkatesan AM Image Fusion Technology in Interventional Radiology. Tech Vasc Interv Radiol 26(3):100915, 2023. PMID: 38071026.
- Lupinelli M, Sbarra M, Kilcoyne A, Venkatesan AM, Nougaret S MR Imaging of Gynecologic Tumors: Pearls, Pitfalls, and Tumor Mimics. Radiol Clin North Am 61(4):687-711, 2023. PMID: 37169432.
- Jacobsen MC, Maheshwari E, Klopp AH, Venkatesan AM Image-Guided Radiotherapy for Gynecologic Malignancies: What the Radiologist Needs to Know. Radiol Clin North Am 61(4):725-747, 2023. PMID: 37169434.
- Sbarra M, Lupinelli M, Brook OR, Venkatesan AM, Nougaret S Imaging of Endometrial Cancer. Radiol Clin North Am 61(4):609-625, 2023. PMID: 37169427.
- Recht HS, Shampain KL, Flory MN, Nougaret S, Barber EL, Jha P, Maturen KE, Sadowski EA, Shinagare AB, Venkatesan AM, Horowitz JM Gynecologic oncology tumor board: the central role of the radiologist. Abdom Radiol (NY). PMID: 37386301.
- Urologic Imaging EPO, Turkbey B, Oto A, Allen BC, Akin O, Alexander LF, Ari M, Froemming AT, Fulgham PF, Gettle LM, Maranchie JK, Rosenthal SA, Schieda N, Schuster DM, Venkatesan AM, Lockhart ME ACR Appropriateness Criteria® Post-Treatment Follow-up of Prostate Cancer: 2022 Update. J Am Coll Radiol 20(5S):S164-S186, 2023. PMID: 37236741.
- Maheshwari E, Nougaret S, Stein EB, Rauch GM, Hwang KP, Stafford RJ, Klopp AH, Soliman PT, Maturen KE, Rockall AG, Lee SI, Sadowski EA, Venkatesan AM Update on MRI in Evaluation and Treatment of Endometrial Cancer. Radiographics 42(7):2112-2130, 2022. PMID: 36018785.
- Elshaikh MA, Modh A, Jhingran A, Biagioli MC, Coleman RL, Gaffney DK, Harkenrider MM, Heskett K, Jolly S, Kidd E, Lee LJ, Li L, Portelance L, Sherertz T, Venkatessan AM, Wahl AO, Yashar CM, Small W Executive summary of the American Radium Society® Appropriate Use Criteria for management of uterine carcinosarcoma. Gynecol Oncol 158(2):460-466, 2020. PMID: 32475772.
- Consul N, Venkatesan AM, Blair KJ, Morshid A, Menias CO, Shaaban AM, Elmohr MM, Gaballah AH, Elsayes KM Calcified Adrenal Lesions: Pattern Recognition Approach on Computed Tomography With Pathologic Correlation. J Comput Assist Tomogr 44(2):178-187, 2020. PMID: 32195796.
- Jones KM, Michel KA, Bankson JA, Fuller CD, Klopp AH, Venkatesan AM Emerging magnetic resonance imaging technologies for radiation therapy planning and response assessment. Int J Radiat Oncol Biol Phys 101(5):1046-1056, 2018. PMID: 30012524.
- Pillai AK, Kalva SP, Hsu SL, Walker TG, Silberzweig JE, Annamalai G, Baerlocher MO, Mitchell JW, Midia M, Nikolic B, Dariushnia SR Quality Improvement Guidelines for Mesenteric Angioplasty and Stent Placement for the Treatment of Chronic Mesenteric Ischemia. J Vasc Interv Radiol 29(5):642-647, 2018. PMID: 29574024.
- Venkatesan AM, Stafford RJ, Duran C, Soni PD, Berlin A, McLaughlin PW Prostate MRI for brachytherapists: diagnosis, imaging pitfalls, and post-therapy assessment. Brachytherapy. PMID: 28139419.
- Copelan A, Hartman J, Chehab M, Venkatesan AM High-intensity focused ultrasound: current status for image-guided therapy. Semin Intervent Radiol 32(4):398-415, 2015. PMID: 26622104.
- Chehab MA, Brinjikji W, Copelan A, Venkatesan AM Navigational tools for interventional radiology and interventional oncology applications. Semin Intervent Radiol 32(4):416-27, 2015. PMID: 26622105.
- of Radiology AC, Interventional Radiology SO, Neurointerventional Surgery SO Practice parameter for interventional clinical practice and management. J Vasc Interv Radiol 26(8):1197-204, 2015. PMID: 26142141.
- Dariushnia SR, Gill AE, Martin LG, Saad WE, Baskin KM, Caplin DM, Kalva SP, Hogan MJ, Midia M, Siddiqi NH, Walker TG, Nikolic B Quality improvement guidelines for diagnostic arteriography. J Vasc Interv Radiol 25(12):1873-81, 2014. PMID: 25241301.
- Sheth RA, Walker TG, Saad WE, Dariushnia SR, Ganguli S, Hogan MJ, Hohenwalter EJ, Kalva SP, Rajan DK, Stokes LS, Zuckerman DA, Nikolic B Quality improvement guidelines for vascular access and closure device use. J Vasc Interv Radiol 25(1):73-84, 2014. PMID: 24209907.
- Koethe Y, Widemann BC, Hajjar F, Wood BJ, Venkatesan AM PET-guided biopsy with needle navigation facilitates diagnosis of angiosarcoma in neurofibromatosis type 1. Pediatr Blood Cancer 60(12):E166-9, 2013. PMID: 23922330.
- Devine K, McCluskey T, Henne M, Armstrong A, Venkatesan AM, Decherney A Is magnetic resonance imaging sufficient to diagnose rudimentary uterine horn? A case report and review of the literature. J Minim Invasive Gynecol 20(4):533-6, 2013. PMID: 23535077.
- Lewis EI, Chason RJ, DeCherney AH, Armstrong A, Elkas J, Venkatesan AM Novel hormone treatment of benign metastasizing leiomyoma: an analysis of five cases and literature review. Fertil Steril 99(7):2017-24, 2013. PMID: 23465706.
- Abi-Jaoudeh N, Kruecker J, Kadoury S, Kobeiter H, Venkatesan AM, Levy E, Wood BJ Multimodality image fusion-guided procedures: technique, accuracy, and applications. Cardiovasc Intervent Radiol 35(5):986-98, 2012. PMID: 22851166.
- Patel IJ, Davidson JC, Nikolic B, Salazar GM, Schwartzberg MS, Walker TG, Saad WA, Practice Committee SO, Cardiovascular W, Europe Endorsement IRSO Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions. J Vasc Interv Radiol 23(6):727-36, 2012. PMID: 22513394.
- Leiding JW, Freeman AF, Marciano BE, Anderson VL, Uzel G, Malech HL, DeRavin S, Wilks D, Venkatesan AM, Zerbe CS, Heller T, Holland SM Corticosteroid therapy for liver abscess in chronic granulomatous disease. Clin Infect Dis 54(5):694-700, 2012. PMID: 22157170.
- Trivedi H, Turkbey B, Rastinehad AR, Benjamin CJ, Bernardo M, Pohida T, Shah V, Merino MJ, Wood BJ, Linehan WM, Venkatesan AM, Choyke PL, Pinto PA Use of patient-specific MRI-based prostate mold for validation of multiparametric MRI in localization of prostate cancer. Urology 79(1):233-9, 2012. PMID: 22202553.
- Venkatesan AM, Wood BJ, Gervais DA Percutaneous ablation in the kidney. Radiology 261(2):375-91, 2011. PMID: 22012904.
- Caplin DM, Nikolic B, Kalva SP, Ganguli S, Saad WE, Zuckerman DA Quality improvement guidelines for the performance of inferior vena cava filter placement for the prevention of pulmonary embolism. J Vasc Interv Radiol 22(11):1499-506, 2011. PMID: 21890380.
- Buckner CA, Venkatesan AM, Locklin JK, Wood BJ Real-time sonography with electromagnetic tracking navigation for biopsy of a hepatic neoplasm seen only on arterial phase computed tomography. J Ultrasound Med 30(2):253-6, 2011. PMID: 21266564.
- Venkatesan AM, Kundu S, Sacks D, Wallace MJ, Wojak JC, Rose SC, Clark TW, d'Othee BJ, Itkin M, Jones RS, Miller DL, Owens CA, Rajan DK, Stokes LS, Swan TL, Towbin RB, Cardella JF, Practice Committee SOIRSO Practice guidelines for adult antibiotic prophylaxis during vascular and interventional radiology procedures. Written by the Standards of Practice Committee for the Society of Interventional Radiology and Endorsed by the Cardiovascular Interventional Radiological Society of Europe and Canadian Interventional Radiology Association [corrected]. J Vasc Interv Radiol 21(11):1611-30; quiz 1631, 2010. PMID: 21029949.
- Wood BJ, Kruecker J, Abi-Jaoudeh N, Locklin JK, Levy E, Xu S, Solbiati L, Kapoor A, Amalou H, Venkatesan AM Navigation systems for ablation. J Vasc Interv Radiol 21(8 Suppl):S257-63, 2010. PMID: 20656236.
- Dariushnia SR, Wallace MJ, Siddiqi NH, Towbin RB, Wojak JC, Kundu S, Cardella JF Quality improvement guidelines for central venous access. J Vasc Interv Radiol 21(7):976-81, 2010. PMID: 20610180.
- Gupta S, Wallace MJ, Cardella JF, Kundu S, Miller DL, Rose SC Quality improvement guidelines for percutaneous needle biopsy. J Vasc Interv Radiol 21(7):969-75, 2010. PMID: 20304676.
- Sharma KV, Venkatesan AM, Swerdlow D, DaSilva D, Beck A, Jain N, Wood BJ Image-guided adrenal and renal biopsy. Tech Vasc Interv Radiol 13(2):100-9, 2010. PMID: 20540919.
- Venkatesan AM, Locklin J, Dupuy DE, Wood BJ Percutaneous ablation of adrenal tumors. Tech Vasc Interv Radiol 13(2):89-99, 2010. PMID: 20540918.
- Khilnani NM, Grassi CJ, Kundu S, D'Agostino HR, Khan AA, McGraw JK, Miller DL, Millward SF, Osnis RB, Postoak D, Saiter CK, Schwartzberg MS, Swan TL, Vedantham S, Wiechmann BN, Crocetti L, Cardella JF, Min RJ, of Europe CIRS, of Phlebology AC Multi-society consensus quality improvement guidelines for the treatment of lower-extremity superficial venous insufficiency with endovenous thermal ablation from the Society of Interventional Radiology, Cardiovascular Interventional Radiological Society of Europe, American College of Phlebology and Canadian Interventional Radiology Association. J Vasc Interv Radiol 21(1):14-31, 2010. PMID: 20123189.
- Kundu S, Grassi CJ, Khilnani NM, Fanelli F, Kalva SP, Khan AA, McGraw JK, Maynar M, Millward SF, Owens CA, Stokes LS, Wallace MJ, Zuckerman DA, Cardella JF Multi-disciplinary quality improvement guidelines for the treatment of lower extremity superficial venous insufficiency with ambulatory phlebectomy from the Society of Interventional Radiology, Cardiovascular Interventional Radiological Society of Europe, American College of Phlebology and Canadian Interventional Radiology Association. J Vasc Interv Radiol 21(1):1-13, 2010. PMID: 19959374.
- Malloy PC, Grassi CJ, Kundu S, Gervais DA, Miller DL, Osnis RB, Postoak DW, Rajan DK, Sacks D, Schwartzberg MS, Zuckerman DA, Cardella JF, with Cardiovascular SOPC, Europe Endorsement IRSO Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions. J Vasc Interv Radiol 20(7 Suppl):S240-9, 2009. PMID: 19394868.
- Sahani DV, Lin DJ, Venkatesan AM, Sainani N, Mino-Kenudson M, Brugge WR, Fernandez-Del-Castillo C Multidisciplinary approach to diagnosis and management of intraductal papillary mucinous neoplasms of the pancreas. Clin Gastroenterol Hepatol 7(3):259-69, 2009. PMID: 19121413.
- Stone MJ, Venkatesan AM, Locklin J, Pinto P, Linehan M, Wood BJ Radiofrequency ablation of renal tumors. Tech Vasc Interv Radiol 10(2):132-9, 2007. PMID: 18070691.
- Venkatesan AM, Dunaif A, Corbould A Insulin resistance in polycystic ovary syndrome: progress and paradoxes. Recent Prog Horm Res 56:295-308, 2001. PMID: 11237218.
Abstracts
- Jones K, Michel K, Solley T, Dorta-Estremera, Sastry J, Wei W, Bankson J, Klopp A, Venkatesan AM. Amide proton transfer imaging of early radiotherapy response in high-risk HPV+ gynecologic cancer. Scientific Assembly and Annual Meeting Radiological Society of North America, 2017. e-Pub 2017.
- Morshid A, Menias C, Shaaban A, Gaballah A, Venkatesan AM, Elsayes K. Calcified adrenal masses; pattern recognition approach on computed tomography with pathologic correlation. Scientific Assembly and Annual Meeting Radiological Society of North America, 2017. e-Pub 2017.
- Venkatesan AM. Pearls and pitfalls in prostate MRI: the 2016 update. Scientific Meeting and Education Course Society of Abdominal Imaging, 2016. e-Pub 2016.
- Venkatesan, AM. Gastrointestinal abnormalities on CT in chronic granulomatous disease, 2015. e-Pub 2015.
- Venkatesan, AM. Challenging image-guided biopsies and the role for needle navigation and image fusion. Society of Abdominal Radiology Annual Scientific Meeting and Education Course, 2015. e-Pub 2015.
- Venkatesan, AM. HIFU: technical and clinical progress of a disruptive ablation technology. Society of Interventional Radiology Annual Scientific Meeting, 2015. e-Pub 2015.
- Venkatesan AM. Oncologic spplications of HIFU in 2014-current state-of-the-art and future directions. Radiological Society of North America Scientific Assembly and Annual Meeting, 2014. e-Pub 2014.
- Duffy AG, Ma C, Ulahannan SV, Fioraventi S, Venkatesan AM, Turkbey IB, Choyke PL, Trepel JB, Liang C, Compton K, Figg WD, Greten TF. TRC105 for the treatment of hepatocellular carcinoma: preclinical data and preliminary results from two clinical trials evaluating monotherapy and combination with sorafenib. 2014 Gastrointestinal Cancers Symposium (GI ASCO), 2014. e-Pub 2014.
- Koethe Y, Xu S, Velusamy G, Wood BJ, Venkatesan AM. Evaluation of a novel robotic navigation and guidance platform for image-guided interventions. National Center for Image Guided Therapy (NCIGT) and NIH Image Guided Therapy Workshop, 2013. e-Pub 2013.
- Koethe Y, Xu S, Velusamy G, Wood BJ, Venkatesan AM. Robotic navigation and guidance for percutaneous CT-guided interventions. World Conference of Interventional Oncology (WCIO), 2013. e-Pub 2013.
- Partanen A, Yerram NK, Trivedi H, Dreher MR, Oila J, Hoang AN, Volkin D, Nix J, Turkbey B, Bernardo M, Haines DC, Compton BJ, Linehan WM, Choyke P, Wood BJ, Ehnholm GJ, Venkatesan AM, Pinto PA. Magnetic resonance imaging-guided transurethral ultrasound therapy of the prostate: a feasibility study in canines with radiologic and pathologic correlation. Society for Thermal Medicine Annual Scientific Meeting, 2013. e-Pub 2013.
- Venkatesan AM, Dreher MR, Partanen A, Yarmolenko P, Wood BJ. Interventional thermoablative therapies for cancer-current clinical approach and future directions. Society for Thermal Medicine Annual Scientific Meeting, 2012. e-Pub 2012.
- Trivedi H, Venkatesan AM, Adams KT, Kebebew E, Pacak K. Comparison of clinical and imaging features in succinate dehydrogenase beta positive versus sporadic paragangliomas. American Association of Endocrine Surgeons Annual Scientific Meeting, 2011. e-Pub 2011.
- Venkatesan AM. Radiofrequency ablation for metastatic pheochromocytoma. Abdominal Radiology Course, 2011. e-Pub 2011.
- Pulanic T, Venkatesan AM, Segars J, Locklin J, Wood BJ, Stratton P. Novel use of a vaginal pessary to optimize the position the uterus for magnetic resonance imaging-guided high intensity focused ultrasound ablation of uterine fibroids. Society for Gynecologic Investigation Annual Scientific Meeting, 2010. e-Pub 2010.
- Venkatesan AM, Stratton P, Segars, J, Merino M, Sokka S, Wood BJ. A novel graphical user interface for MR-guided high intensity focused ultrasound volumetric ablation of uterine fibroids. International Society for Therapeutic Ultrasound, 2009. e-Pub 2009.
- Venkatesan AM, Locklin J, Lai E, Adams K, Fojo A, Pacak K, Wood BJ. Radiofrequency ablation for metastatic pheochromocytoma: safety, clinical efficacy and hemodynamic management. Society of Interventional Radiology Annual Scientific Meeting, 2009. e-Pub 2009.
- Venkatesan AM, Locklin J, Xu S, Kruecker J, Glossop N, Wood BJ. Early clinical experience with CT- and US-18FDG-PET fusion for guidance during biopsies and radiofrequency ablations. Radiological Society of North America Scientific Assembly and Annual Meeting, 2008. e-Pub 2008.
- Venkatesan AM, Azad N, Annunziata CM, Wood BJ, Kohn EC. Imaging features and management of pulmonary and gastrointestinal toxicities during systemic antiangiogenic therapy. Radiological Society of North America Scientific Assembly and Annual Meeting, 2008. e-Pub 2008.
- Venkatesan AM, Kruecker J, Xu S, Locklin JJ, Pinto PA, Choyke P, Singh AK, Glossop N, Wood BJ. Early clinical experience with real time ultrasound-MRI fusion guided prostate biopsies. Society of Interventional Radiology Annual Scientific Meeting, 2008. e-Pub 2008.
- Venkatesan AM, Holalkere NS, Hahn P, Lee S. Diffusion-weighted MR imaging of the female pelvis at 1.5 and 3.0 T: a comparative study of apparent diffusion coefficient (ADC) values of normal gynecologic anatomy. Radiological Society of North America Scientific Assembly and Annual Meeting, 2007. e-Pub 2007.
- Venkatesan AM, Sahani D, Mueller P. Imaging features of intraductal papillary and mucinous neoplasm (IPMN): comparison of MDCT, MRCP, and EUS. Radiological Society of North America Scientific Assembly and Annual Meeting, 2005. e-Pub 2005.
- Venkatesan AM, Sahani D, Fernandez C, Prabhakar H, Mueller P. Imaging features and evolving management of intraductal papillary and mucinous neoplasm of the pancreas (IPMN): a multimodality assessment with radiologic/pathologic correlation. Radiological Society of North America Scientific Assembly and Annual Meeting, 2005. e-Pub 2005.
- Venkatesan AM, Fritz B, Kassarjian A, Palmer W. Correlation between the size of rotator cuff tear and the degree of tendon retraction; importance of tendon delamination. Radiological Society of North America Scientific Assembly and Annual Meeting, 2005. e-Pub 2005.
- Venkatesan AM, Roccatagliata L, Murphy E, Schaefer P, Gonzalez R, Lev M. CTA source images (CTA-SI) in hyperacute stroke correlate with CT-CBV and MR-DWI, but not CT-CBF. Radiological Society of North America Scientific Assembly and Annual Meeting, 2003. e-Pub 2003.
- Venkatesan AM, Corbould A, Dunaif A. Decreased phosphorylation of glycogen synthase kinase in skin fibroblasts from women with polycystic ovary syndrome. ENDO 2000: The Endocrine Society 82nd Annual Meeting, 2000. e-Pub 2000.
- Venkatesan AM. Decreased phosphorylation of glycogen synthase kinase in cultured skin fibroblasts from Women with polycystic ovary syndrome (PCOS). Howard Hughes Medical Institute 2000 Meeting of Medical Student Fellows, 2000. e-Pub 2000.
- Venkatesan AM. Decreased phosphorylation of glycogen synthase kinase in skin fibroblasts from women with polycystic ovary syndrome. Harvard Medical School 60th Annual Soma Weiss Research Day, 2000. e-Pub 2000.
- Glanz BI, Venkatesan AM, Schur PS, Khoshbin S. Migraine in patients with systemic lupus erythematosus. Neurology(A201-202):. 52(Supp. 2), 1999. e-Pub 1999.
- Venkatesan, AM. English as a second language—a step towards empowerment and an end to the cycle of violence. The ESL Program of the Asian Task Force Against Domestic Violence. Harvard Medical School Ebert Community Service Poster Session, 1998. e-Pub 1998.
- Venkatesan AM, Huang E, Scharf M, Mayer E, Khush K. The Harvard Medical School chapter of the American Medical Women’s Association (A.M.W.A.); activities, accomplishments, and future directions. Harvard Medical School Ebert Community Service Poster Session, May 1997, Boston, 1997. e-Pub 1997.
- Venkatesan AM. Isolation and cloning of alternatively spliced cDNA fragments using reverse transcriptase PCR cloning. National Institutes of Health Student Poster Session, 1995. e-Pub 1995.
- Venkatesan AM. Isolation of the transcriptional start site of the murine rpx (Rathke’s pouch) homeobox gene. National Institutes of Health Student Poster Session, 1994. e-Pub 1994.
- Venkatesan AM. Characterization and transcriptional analysis of the murine Nkx-3.1 homeobox gene. National Institutes of Health Student Poster Session, 1993. e-Pub 1993.
- Mahon KA, Amesse LA, Venkatesan AM, Gleizer L. Nkx-3.1: A novel homeobox gene expressed in developing somites. Journal of Cellular Biochemistry, 1993. e-Pub 1993.
- Venkatesan AM. Comparative expression in the developing forebrain of members of a new family of murine distal-less homeobox genes. National Institutes of Health Student Poster Session, 1992. e-Pub 1992.
Book Chapters
- M Chehab, Venkatesan AM. Female Genitourinary Imaging. In: Brant and Helm’s Fundamentals of Radiology, 1259-1301, 2024.
- Guo C, Bhosale PR, Rauch GM, Matamoros A, Menias C, Schmeler KM, Iyer RB, Venkatesan AM. Tumors of the Uterine Corpus. In: Oncologic Imaging, A Multidisciplinary Approach. Elsevier, 414-437, 2021.
- Chehab M, Antypas E, Kirsch MJ, Venkatesan AM. Perioprocedural Evaluation: Antibiotics. In: Fundamentals of Interventional Radiology Clinical Management. 1. Oxford University Press, 9-20, 2019.
- Venkatesan AM, Wood BJ. Adrenal Cancer: Ablation. In: Interventional Oncology.Ed(s) Faintuch S. Ganguli R. Gandi. Thieme Publishers: New York, NY. 2015. Thieme Publishers, 16-33, 2016.
- Venkatesan AM, Wood BJ. Principles of high intensity focused ultrasound. In: Interventional Oncology: Principles & Practice of lmage-Guided Cancer Therapy, 2nd edition. Ed(s) J.F. Geschwind, M. Soulen. Cambridge University Press: Cambridge UK. 2016. Cambridge University Press, 20-34, 2016.
- Cookingham LM, Armstrong AY, Venkatesan AM, Segars JH. Rare fibroid syndromes. In: Fibroids (Gynecology in Practice). Wiley-Blackwell, 120-133, 2013.
- Venkatesan, AM. Advanced tools and devices-navigation technologies, automation and robotics in percutaneous interventions. In: Ahrar K, Gupta S, eds. Percutaneous Image Guided Biopsy. Springer, 73-83, 2013.
Selected Presentations & Talks
Local Presentations
- 2023. Accelerating Cancer Research through Predictive Modeling and Advanced Computing. Conference. 4th Annual Research Retreat of the Joint Center for Computational Oncology (JCCO). HOUSTON, TX, US.
- 2023. 4th Annual Research Retreat of the Joint Center for Computational Oncology (JCCO). Conference. 4th Annual Research Retreat of the Joint Center for Computational Oncology (JCCO). HOUSTON, TX, US.
- 2023. Alkek Magnetic Resonance Imaging Decreasing Dependency of General Anesthesia for Outpatients. Conference. 2023 DI Celebrate Solutions, US.
- 2023. Remote MRI Monitoring and Scan Control Using the syngo Virtual Cockpit at MD Anderson: Opportunities and Lessons Learned from the Medical Imaging Technologist Perspective. Conference. 2023 DI Celebrate Solutions, US.
- 2023. Panelist. Conference. 2023 UT MDACC Cancer Network Genitourinary Integration Retreat, US.
- 2022. Panelist. Conference. 2022 UT MDACC Cancer Network Genitourinary Integration Retreat, US.
- 2011. Comparison of clinical and imaging features in succinate dehydrogenase beta positive verses sporadic paragangliomas. Conference. American Association of Endrocrine Surgeons. HOUSTON, TX, US.
Regional Presentations
- 2021. Diffusion profiling via a histogram approach in locally advanced cervical cancer treated with chemoradiotherapy: challenges and opportunities for dynamic targeting with MRI. Conference. American Association of Physicists in Medicine 63rd Annual Meeting and Convention, US.
National Presentations
- 2024. Imaging and Management of Endometrial Cancer in 2024: What the Abdominal Radiologist Needs to Know. Invited. Society of Abdominal Radiology Annual Scientific Meeting and Education Course. Austin, TX, US.
- 2023. Preliminary evaluation of diffusion-weighted MRI and HPV-specific circulating tumor DNA clearance in HPV-positive cervical cancer. Invited. Radiological Society of North America Scientific Assembly and Annual Meeting. Chicago, IL, US.
- 2023. Imaging Considerations for the Evaluation and Management of Cervical Cancer: A 2023 Update. Invited. Society of Abdominal Radiology Annual Scientific Meeting and Education Course. Austin, TX, US.
- 2023. Pearls and Pitfalls in Gynecologic MRI. Invited. Society of Abdominal Radiology Annual Scientific Meeting and Education Course. Austin, TX, US.
- 2022. Development and Optimization of Multiparametric MRI for Bladder Cancer: Opportunities for Standardization and Quality Improvement. Conference. Radiological Society of North America Scientific Assembly and Annual Meeting. Chicago, IL, US.
- 2022. GU Essentials – A Case Based Audience Participation Session: Malignant Gynecology. Invited. Radiological Society of North America Scientific Assembly and Annual Meeting. Chicago, IL, US.
- 2022. Endometrial Cancer: Lymph Node Sampling? Plenary Session VII: Get it Right in Gynecologic Oncology: Key Decisions Guided by Imaging. Invited. Society for Abdominal Radiology Annual Scientific Meeting and Education Course, US.
- 2022. Gynecologic Imaging: Cases for Aces Webinar. Invited. Gynecologic Imaging: Cases for Aces Webinar, US.
- 2021. Histogram Profiling of Apparent Diffusion Coefficients in locally advanced cervical cancer treated with chemoradiotherapy. Conference. Radiological Society of North America Scientific Assembly and Annual Meeting, US.
- 2021. Gynecology Oncology Tumor Board: How the radiologist adds value. Conference. Radiological Society of North America Scientific Assembly and Annual Meeting, US.
- 2021. Computer-aided identification of clinically significant prostate lesions in multiparametric MRI for low-dose-rate prostate brachytherapy treatment planning. Conference. Radiological Society of North America Scientific Assembly and Annual Meeting, US.
- 2021. Recurrent Tumors Of The Uterine Cervix And Corpus: Multimodality Imaging Review And Implications For Clinical Management. Conference. Radiological Society of North America Scientific Assembly and Annual Meeting, US.
- 2021. The 2021 Update on MRI for Endometrial Cancer: What the Radiologist Needs to Know. Conference. Radiological Society of North America Scientific Assembly and Annual Meeting, US.
- 2021. Normalization of Temperature Effects for Improved Quantitative Prostate Apparent Diffusion Coefficient (ADC) Imaging Across Multiple Sites. Conference. Radiological Society of North America Scientific Assembly and Annual Meeting, US.
- 2021. Direct MR-guidance of Brachytherapy in Gynecologic Cancers: Workflow Considerations, Technical Development, and Clinical Benefits. Conference. Radiological Society of North America Scientific Assembly and Annual Meeting, US.
- 2021. Interactive GU Session: Malignant Gynecology. Invited. Radiological Society of North America Scientific Assembly and Annual Meeting. Chicago, IL, US.
- 2021. Assessment of Local Treatment Response for Cervical Cancer: Critical Concepts & Role for Multimodality Imaging. Conference. Radiological Society of North America Scientific Assembly and Annual Meeting. Chicago, IL, US.
- 2021. Performance of Intra-procedural Apparent Diffusion Coefficient Imaging during MRI Guided Cervical Cancer Brachytherapy: Opportunities for Image-Guided Adaptive Radiotherapy. Invited. Society of Abdominal Radiology Digital Annual Scientific Meeting and Education Course, US.
- 2021. Practical Strategies for Performing Hybrid Interstitial applicators for Cervical Cancer. Invited. American Brachytherapy Society Webinar, US.
- 2020. State of the Art in Anatomical MR Imaging for Radiotherapy Planning & Guidance. Conference. Radiological Society of North America Scientific Assembly and Annual Meeting. Chicago, IL, US.
- 2020. SAR Uterine and Ovarian Cancer Disease-focused panel staging lexicon and template for ovarian cancer. Invited. Society of Abdominal Radiology Annual Scientific Meeting and Education Course. Maui, HI, US.
- 2020. MRI of Cervical, Myometrial and Endometrial Lesions. Invited. Society of Abdominal Radiology Annual Scientific Meeting and Education Course. Maui, HI, US.
- 2020. Case-Based Session: Challenging Clinical Scenarios in the Management of Renal Cell Carcinoma. Invited. 2020 Genitourinary Cancers Symposium. San Francisco, CA, US.
- 2019. Prostate Cancer Diagnosis and Staging. Invited. 2019 Annual Meeting. Honolulu, HI, US.
- 2019. Cervical Cancer: Brachytherapy and Beyond. Invited. SAR 2019 Annual Scientific Meeting. Orlando, FL, US.
- 2018. Optimizing MRI Sequences for Brachytherapy. Invited. ABS-MD Anderson Winter Prostate and GYN School and Prostate LDR/HDR Workshop. Houston, TX, US.
- 2018. Prostate Imaging During the Recurrent Setting. Invited. ABS-MD Anderson Winter Prostate and GYN School and Prostate LDR/HDR Workshop. Houston, TX, US.
- 2018. Genitourinary (new techniques in prostate imaging and intervention). Invited. Scientific Assembly and Annual Meeting, US.
- 2018. State of the art in anatomical MR imaging. Invited. Scientific Assembly and Annual Meeting. Chicago, IL, US.
- 2018. Role of PET Imaging for Recurrent/Metastatic Prostate Cancer. Invited. 13th Update on the Management of Genitourinary Malignancies. Houston, TX, US.
- 2018. MRI of Gynecologic Malignancies. Invited. Annual Scientific Meeting. Washington, DC, US.
- 2018. Pearls and pitfalls of prostate cancer imaging. Invited. The Cancer Imaging and Intervention Conference. Houston, TX, US.
- 2018. Cervical cancer: brachytherapy and beyond. Invited. Annual Scientific Meeting. Scottsdale, AZ, US.
- 2017. MRI for radiotherapy planning of HPV-associated gynecologic cancers: what the radiologist needs to know. Conference. Radiological Society of North America. Chicago, IL, US.
- 2017. Calcified adrenal masses; pattern recognition approach on computed tomography with pathologic correlation. Invited. Scientific Assembly and Annual Meeting. Chicago, IL, US.
- 2017. Imaging for renal masses: what should we use in 2017?. Invited. Scientific Assembly and Annual Meeting. Chicago, IL, US.
- 2016. Pearls and pitfalls in prostate MRI: the 2016 update. Invited. Scientific Meeting and Education Course. Hollywood, FL, US.
- 2015. Pearls and pitfalls of prostate MRI. Invited. Scientific Assembly and Annual Meeting. Chicago, IL, US.
- 2015. Complications related to imaging interpretive errors. Invited. Scientific Assembly and Annual Meeting. Chicago, IL, US.
- 2015. Gastrointestinal Imaging - Bowel. Conference. American Roentgen Ray Society Annual Meeting. Toronto, CA.
- 2015. Gastrointestinal abnormalities on CT in chronic granulomatous disease. Invited. Annual Meeting, US.
- 2015. Challenging Image Guided Biopsies and Role for image Fusion and Needle Navigation. Conference. Society of Abdominal Radiology Annual Scientific Meeting and Education Course. San Diego, CA, US.
- 2015. HIFU: technical and clinical progress of a disruptive ablation technology. Invited. Annual Scientific Meeting, US.
- 2014. Imaging and Clinical Features of Lesions Suspicious for Malignant Transformation in Neurofibromatosis. Conference. Radiological Society of North America Scientific Assembly and Annual Meeting. Chicago, IL, US.
- 2013. Pearls and pitfalls of a successful SIR Grant Submission. Conference. Society of Interventional Radiology Resident and Fellow Section. Unknown, US.
- 2013. Navigation tools and video games in IR and Interventional Oncology [Scientific Workshop]. Conference. 38th Annual Scientific Meeting. New Orleans, LA, US.
- 2012. Interventional thermoablative therapies for cancer-current clinical approach and future directions. Invited. Annual Scientific Meeting. Portland, OR, US.
- 2012. Navigation tools and video games in IR and Interventional Oncology [Scientific Workshop]. Conference. 37th Annual Scientific Meeting. San Francisco, CA, US.
- 2011. Navigation tools and video games in Interventional Radiology [Scientific Workshop]. Conference. 36th Annual Scientific Meeting. Chicago, IL, US.
- 2010. Imaging and follow-up after regional therapies: tumor markers imaging, functional imaging, frequency of office visits and indications for retreatment. Invited. 37th Annual Symposium on Vascular and Interventional Issues (VEITH Symposium). New York, NY, US.
- 2010. Navigation tools and video games in IR and Interventional Oncology [Scientific Workshop]. Conference. Scientific of Interventional Radiology Annual Scientific Meeting. Tampa, FL, US.
- 2010. Novel use of a vaginal pessary to optimize the position the uterus for magnetic resonance imaging-guided high intensity focused ultrasound ablation of uterine fibroids. Invited. Society for Gynecologic Investigation Annual Scientific Meeting. Orlando, FL, US.
- 2009. Radiofrequency ablation for metastatic pheochromocytoma - a minimally invasive image-guided treatment option. Invited. Pheo-Para Alliance: Pheochromocytoma and Paraganglioma Conference. Parsippany, NJ, US.
- 2009. Radiofrequency ablation for metastatic pheochromocytoma: safety, clinical efficacy and hemodynamic management. Invited. Annual Scientific Meeting. San Diego, CA, US.
- 2008. Early clinical experience with CT- and US-18FDG-PET fusion for guidance during biopsies and radiofrequency ablations. Invited. Scientific Assembly and Annual Meeting, US.
- 2008. Imaging features and management of pulmonary and gastrointestinal toxicities during systemic antiangiogenic therapy. Invited. Scientific Assembly and Annual Meeting. Chicago, IL, US.
- 2008. Early clinical experience with real time ultrasound-MRI fusion guided prostate biopsies. Invited. Society of Interventional Radiology Annual Scientific Meeting. Washington, DC, US.
- 2007. Diffusion-weighted MR imaging of the female pelvis at 1.5 and 3.0 T: A comparative study of apparent diffusion coefficient (ADC) values of normal gynecologic anatomy. Invited. Radiological Society of North America Scientific Assembly and Annual Meeting. Chicago, IL, US.
- 2005. Correlation between the size of rotator cuff tear and the degree of tendon retraction: Importance of tendon delamination. Invited. Radiological Society of North America Scientific Assembly and Annual Meeting. Chicago, IL, US.
- 2005. Imaging features of intraductal papillary and mucinous neoplasm (IPMN): Comparison of MDCT, MRCP and EUS. Invited. Radiological Society of North America Scientific Assembly and Annual Meeting. Chicago, IL, US.
- Imaging and follow-up after regional therapies markers imaging, functional imaging, frequency of office visits: tumor and indications for retreatment. Visiting. 37th Annual Symposium on Vascular and Interventional Issues (VEITH Symposium). New York, NY, US.
- Radiofrequency ablation for metastatic pheochromocytoma – a minimally invasive image-guided treatment option. Visiting. Pheo-Para Alliance: Pheochromocytoma and Paraganglioma Conference. Parsippany, NJ, US.
- Complications of image-guided ablation. Visiting. European Conference on Interventional Oncology. Florence, IT.
- US pilot study of MRI-guided high intensity focused ultrasound ablation of uterine fibroids. Visiting. 2nd International Symposium on MR-guided focused ultrasound. Chantilly, VA, US.
International Presentations
- 2024. Pelvic Complications in Gynecologic Cancer. Invited. 30th European Symposium on Urogenital Radiology (ESUR) 2024 Annual Meeting. Lisbon, PT.
- 2024. Latest SAR Guidelines: What’s New?. Invited. 30th European Symposium on Urogenital Radiology (ESUR) 2024 Annual Meeting. Lisbon, PT.
- 2016. MRI for post treatment assessment & diagnosis with a rising PSA. Invited. World Congress of Brachytherapy. San Francisco, US.
- 2012. Role of anatomical imaging in the management of pheochromocytoma and paraganglioma. Invited. International Symposium on Pheochromocytoma. Washington, DC, US.
- 2010. US pilot study of MRI-guided high intensity focused ultrasound ablation of uterine fibroids. Invited. 2nd International Symposium on MR-guided Focused Ultrasound. Chantilly, US.
- 2010. Navigation, targeting and monitoring in interventional oncology. Invited. European Conference on Interventional Oncology. Florence, IT.
- 2010. Complications of image-guided ablation. Invited. European Conference on Interventional Oncology. Florence, IT.
- 2010. International radiology treatment strategies for hepatocellular carcinoma, including the role of combination therapies and novel navigation systems. Invited. National Institutes of Health Symposium. New Delhi, IN.
- 2010. MR elastography - a novel non-invasive assessment of liver fibrosis and hepatocellular carcinoma. Invited. National Institutes of Health Symposium. New Delhi, IN.
- 2010. Imaging follow up for renal cell carcinoma--is there an algorithm?. Invited. 3rd International Symposium on Focal Therapy and Imaging in Prostate and Renal Cancer. Washington, DC, US.
- 2009. A novel graphical use interface for MR-guided high intensity focused ultrasound volumetric ablation of uterine fibroids. Invited. International Society for Therapeutic Ultrasound. Aix-en-Province, FR.
- 2008. Tumor ablation for pheochromocytoma - a minimally invasive image-guided option. Invited. 2nd International Society on Pheochromocytoma. Cambridge, GB.
- Tumor ablation for pheochromocytoma – a minimally invasive image-guided option. Visiting. The 2nd International Society on Pheochromocytoma. Cambridge, GB.
- MR Elastography – a novel non-invasive assessment of liver fibrosis and hepatocellular carcinoma. Visiting. Institute of Liver and Biliary Diseases-National Institutes of Health Symposium. New Delhi, IN.
- Interventional radiology treatment strategies for hepatocellular carcinoma, including the role of combination therapies and novel navigation systems. Visiting. Institute of Liver and Biliary Diseases-National Institutes of Health Symposium. New Delhi, IN.
- Navigation, targeting and monitoring in interventional oncology. Visiting. European Conference on Interventional Oncology. Florence, IT.
Formal Peers
- 2017. Pearls and Pitfalls in Prostate MRI. Invited. Scottsdale, AZ, US.
- 2014. Radiofrequency ablation of pheochromocytoma. Visiting. Bethesda, MD, US.
- 2013. Radiofrequency ablation of pheochromocytoma. Visiting. Bethesda, MD, US.
- 2013. When anti-retroviral therapy is not enough. Visiting. Bethesda, MD, US.
- 2013. Interventional radiology therapies in the management of hepatocellular carcinoma. Visiting. Bethesda, MD, US.
- 2012. Novel, insidious, progressive, fatal: the discovery of Aspergillus tanneri. Visiting. Bethesda, MD, US.
- 2012. Role of anatomical imaging in the management of pheochromocytoma and paraganglioma. Visiting. Washington, DC, US.
- 2012. Interventional radiology therapies in the management of hepatocellular carcinoma. Visiting. Bethesda, MD, US.
- 2010. Interventional radiology’s role in the care of the pediatric oncology patient and the role of “medical GPS” for biopsy and ablation. Visiting. Bethesda, MD, US.
- 2010. Imaging follow up for renal cell carcinoma—is there an algorithm?. Visiting. Washington, DC, US.
- 2009. Interventional radiology therapies in the management of hepatocellular carcinoma. Visiting. Bethesda, MD, US.
Grant & Contract Support
| Date: | 2025 - 2030 |
| Title: | Interpretable Neural Network Decompositions for Risk Stratification in Precision Medicine |
| Funding Source: | National Institutes of Health |
| Role: | Key |
| Date: | 2025 - 2029 |
| Title: | Defining a globally accessible and pragmatic predictive signature (GAPPS) for locally advanced cervical cancer |
| Funding Source: | National Institutes of Health |
| Role: | Key |
| Date: | 2024 - 2027 |
| Title: | A digital twin for the optimal monitoring and radiotherapy of prostate cancer based on personalized computational forecasts (PCATWIN) |
| Funding Source: | Spanish Ministry of Science, Innovation and Universities, Agencia Estatal de Investigación [National Research Agency] |
| Role: | Key |
| Date: | 2024 - 2027 |
| Title: | Agencia Estatal de Investigación [National Research Agency] |
| Funding Source: | Proyecto’s Generación de Conocimiento 2023 [Knowledge Generation Projects 2023] |
| Role: | Co-I |
| Date: | 2024 - 2029 |
| Title: | Practical Digital Twins for Guidance of Predictive, Personally Optimized Cancer Treatment |
| Funding Source: | NIH |
| Role: | mPI |
| Date: | 2024 - 2025 |
| Title: | Enhancing Cervical Cancer Radiotherapy: Integrating MRI and Circulating HPV DNA for Tailored Treatment Strategies |
| Funding Source: | Institutional Research Grant |
| Role: | PI |
| Date: | 2024 - 2028 |
| Title: | A Phase II multicenter study of chemotherapy versus chemotherapy plus durvalumab in patients with lymph node positive urothelial carcinoma of the bladder |
| Funding Source: | Ingram Family Fund |
| Role: | Co-I |
| Date: | 2024 - 2029 |
| Title: | Integration of Magnetic Resonance Imaging and Blood-based Human Papillomavirus (HPV) DNA Genotyping to Predict Response to Chemoradiotherapy in Cervical Cancer (IMPACT) |
| Funding Source: | NIH |
| Role: | PI |
| ID: | 1R01CA289266 |
| Date: | 2024 - 2025 |
| Title: | Multiparametric MRI Imaging as a Biomarker in Locally Advanced Bladder Cancer (MIRAGE) |
| Funding Source: | NIH |
| Role: | Key |
| Date: | 2023 - 2025 |
| Title: | Imaging-Based Forecasting of Prostate Cancer Histopathology and Progression during Active Surveillance |
| Funding Source: | The Joint Center for Computational Oncology |
| Role: | PI |
| Date: | 2023 - 2028 |
| Title: | Combining Effective Radiotherapeutic-strategies to enhance Vaccinations against Cervical cancer (CERVICAL) ROBIN |
| Funding Source: | Radiation Oncology-Biology Integration Network (ROBIN) Centers (U54 Clinical Trial Required) |
| Role: | Co-Program Leader |
| ID: | 1 U54 CA281787-01 |
| Date: | 2022 - 2025 |
| Title: | Tumor Measurement Initiative |
| Funding Source: | The University of Texas MD Anderson Cancer Center |
| Role: | Key |
| Date: | 2022 - 2026 |
| Title: | Phase 1b/2 study of 177Lu girentuximab plus cabozantinib and nivolumab in treatment naive patients with advanced clear cell RCC |
| Funding Source: | Department of Defense Kidney Cancer Research Program |
| Role: | Co-I |
| Date: | 2022 - 2027 |
| Title: | ROAR C2 - Reduction of Toxicity Using Online Adaptive Radiotherapy for Locally Advanced Cervical Cancer |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | 13516135 |
| Date: | 2022 - Present |
| Title: | An Evidence-Based Focal Cryotherapy Protocol for Focal Ablation of Intermediate Risk Prostate Cancer |
| Funding Source: | Philanthropic Sources |
| Role: | Collaborator |
| ID: | 2022-0165 |
| Date: | 2022 - 2027 |
| Title: | Online Adaptive Radiotherapy to Reduce Toxicity in Locally Advanced Cervical Cancer |
| Funding Source: | NIH/NIBIB |
| Role: | Co-I |
| ID: | 1 R01 CA267646-01A1 |
| Date: | 2021 - 2024 |
| Title: | Patient-specific computational models to forecast prostate cancer growth and progression |
| Funding Source: | Oden Institute for Computational Engineering and Sciences |
| Role: | Co-PI |
| Date: | 2020 - 2023 |
| Title: | Co-Development of Standardized MR Protocols |
| Funding Source: | Siemens/MD Anderson Alliance |
| Role: | PI |
| Date: | 2020 - 2023 |
| Title: | Siemens Strategic Collaboration Alliance: Establishment of a Virtual Operating Center (VOC) at MDACC |
| Funding Source: | Siemens |
| Role: | PI |
| ID: | 57826 Project 3 |
| Date: | 2019 - 2021 |
| Title: | Development of novel positive contrast MRI markers and MRI sequences for precision MRI-Assisted Radio Surgery (MARS) for prostate cancer |
| Funding Source: | MD Anderson - CCSG Radiation Oncology and Cancer Imaging Program |
| Role: | Co-I |
| ID: | P30CA016672 |
| Date: | 2019 - 2023 |
| Title: | Dynamic Targeting using MR Guidance for Precision Radiotherapy |
| Funding Source: | UTMDACC Radiation Oncology Strategic Initiatives (ROSI) Program Seed Grant |
| Role: | Co-PI |
| Date: | 2019 - 2023 |
| Title: | MR Guided Precision Radiosurgery |
| Funding Source: | UTMDACC Radiation Oncology Strategic Initiatives (ROSI) Pilot Grant Program |
| Role: | Co-PI |
| Date: | 2019 - 2020 |
| Title: | Integrated MR Imaging and Tumor Molecular Profiling for Personalized Adaptive Gynecologic Cancer RadioTherapy (IMPACT) |
| Funding Source: | Center for Advanced Biomedical Imaging Pilot Project Program |
| Role: | PI |
| Date: | 2019 - 2020 |
| Title: | Real time IMAging for the treatment of GYNecologic cancers (IMAGYN): MR-Linac based Precision Radiotherapy to Optimize Patient Outcomes |
| Funding Source: | The University of Texas MD Anderson Cancer Center Department of Radiation Oncology Advanced Imaging Initiative Funding for MR-Linac Projects |
| Role: | Co-PI |
| Date: | 2019 - 2021 |
| Title: | Imaging and Targeting the Tumor Microenvironment |
| Funding Source: | Adopt-a-Scientist Foundation |
| Role: | Co-I |
| Date: | 2018 - 2022 |
| Title: | MRI-guided gynecologic brachytherapy: addressing critical unmet clinical needs for image-guided adaptive therapy |
| Funding Source: | The University of Texas MD Anderson CCSG Radiation Oncology and Cancer Imaging Program 2017 Pilot Research Grant |
| Role: | Co-PI |
| Date: | 2018 - 2024 |
| Title: | Addressing Critical Met Needs for Image-Guidance Adaptive Therapy: Value of DWI for Detection and Targeting of Radioresistant HPV-Associated Gynecologic Cancers |
| Funding Source: | The University of Texas MD Anderson Institutional Research Grant |
| Role: | PI |
| Date: | 2017 - 2022 |
| Title: | SPORE for immunologic approaches to HPV-related cancers |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| Date: | 2017 - 2019 |
| Title: | Developing and validating magnetic resonance imaging-assisted radiotherapy to improve the treatment of prostate and gynecologic cancers |
| Funding Source: | 2017 Sabin Family Fellows Foundation Award |
| Role: | PI |
| Date: | 2016 - 2020 |
| Title: | Hyperpolarized 13C-pyruvate MR in prostate cancer |
| Funding Source: | CABI Multi-Investigator Imaging Research Award, GE In-Kind Funding |
| Role: | Collaborator |
| Date: | 2016 - 2018 |
| Title: | Functional and metabolic imaging biomarkers of radiation response in high risk HPV+ tumors |
| Funding Source: | Toshiba America Medical Systems/Radiological Society of North America |
| Role: | PI |
| Date: | 2016 - 2018 |
| Title: | MRI-guided gynecologic brachytherapy and imaging biomarker development: addressing critical unmet needs for image-guided adaptive therapy |
| Funding Source: | Sabin Family Fellows Foundation Award |
| Role: | PI |
| Date: | 2015 - 2019 |
| Title: | Functional imaging and prostate cancer |
| Funding Source: | University of Texas MD Anderson Cancer Center Philanthropy-Koch Functional Imaging and Prostate Cancer Project |
| Role: | Co-I |
| Date: | 2015 - 2016 |
| Title: | Developing an educational curriculum for teaching cancer staging |
| Funding Source: | University of Texas Health Science Education Grants Program |
| Role: | Collaborator |
| Title: | Utilizing [18F]FAZA, DCE MRI, NIR, and Bioluminescence Imaging to Study the Effects of Hypoxia and Reactive Oxygen Species on anti-CTLA-4 Immunotherapy in a Renal Cell Carcinoma (RCC) Mouse Model |
| Funding Source: | Baker Family and Fraydun Foundation |
| Role: | Co-I |
Patient Reviews
CV information above last modified May 22, 2025